Business Contracts
Consumer Forms
Projects
Friends
|
Loading
Drugs and Biotech
Home: Sample Business Contracts: By Industry: Drugs and Biotech
Sponsored Links
aaiPharma Inc.
- 2000 Stock Option Plan for Non-Employee Directors - Applied Analytical Industries Inc. (2000)
- Asset Purchase Agreement - AstraZeneca AB and NeoSan Pharmaceuticals Inc. (Jul 25, 2001)
- Asset Purchase Agreement [Amendment No. 1] - AstraZeneca AB and aaiPharma LLC (Jul 22, 2003)
- Development Agreement - Applied Analytical Industries Inc. and Aesgen Inc. (Apr 4, 1995)
- Development Agreement - Applied Analytical Industries Inc. and GenerEst inc. (Apr 25, 1994)
- Employment Agreement - Applied Analytical Industries Inc. and Frederick D. Sancilio (Nov 17, 1995)
- Employment Agreement - aaiPharma Inc. and Frederick D. Sancilio (Jan 1, 2003)
- Exclusive Option Agreement - Applied Analytical Industries Inc. (May 28, 1996)
- Interim Supply Agreement [Amendment No. 1] - AstraZeneca LP and aaiPharma LLC (Jul 22, 2003)
- Loan Agreement - Applied Analytical Industries Inc. and NationsBank NA (Dec 30, 1996)
- Loan Agreement - Applied Analytical Industries Inc. and NationsBank of North Carolina NA (Dec 21, 1992)
- Loan Agreement - Applied Analytical Industries Inc., AAI Applied Analytical Industries Deutschland GmbH & Co. KG and Bank of America NA (Nov 30, 1999)
- NC-Durham-6110 Quadrangle Drive Lease - I-40 Properties and Applied Analytical Industries Inc. (Dec 23, 1993)
- NC-Wilmington-5051 New Centre Drive Lease - 5051 New Centre Drive LLC and Applied Analytical Industries Inc. (Mar 7, 1994)
- Pledge Agreement - Applied Analytical Industries Inc. and Bank of America NA (Aug 26, 1999)
- Product Sales Agreement - Aesgen Inc. and aaiPharma inc. (Dec 21, 2001)
- Securities Payment Agreement - AAI International Inc., aaiPharma Inc. and Endeavor Pharmaceuticals Inc. (Mar 25, 2003)
- Security Agreement - Applied Analytical Industries Inc. and Bank of America NA (Aug 26, 1999)
- Subscription Agreement - Aesgen Inc. and aaiPharma Inc. (Oct 19, 2001)
ABAXIS Inc.
Abbott Laboratories
- Co-Promotion Agreement - Abbott Laboratories Inc. and Sepracor Inc. (Nov 19, 1999)
- Co-Promotion Agreement - Abbott Laboratories and MedImmune Inc. (Nov 26, 1997)
- Co-Promotion Agreement [Amendment No. 1] - Abbott Laboratories and MedImmune Inc. (Jul 31, 2000)
- Co-Promotion Agreement [Amendment No. 2] - Abbott Laboratories and MedImmune Inc. (Nov 29, 2001)
- Development and Supply Agreement - Cubist Pharmaceuticals Inc. and Abbott Laboratories (Apr 3, 2000)
- Distribution Agreement - MedImmune Inc. and Abbott International Ltd. (Nov 26, 1997)
- Distribution Agreement [Amendment No. 1] - MedImmune Inc. and Abbott International Ltd. (Apr 28, 1999)
- Distribution Agreement [Amendment No. 2] - MedImmune Inc. and Abbott International Ltd. (Oct 8, 1999)
- Distribution Agreement [Amendment No. 3] - MedImmune Inc. and Abbott International Ltd. (Jul 1, 2003)
- License Agreement - Abbott Laboratories and DrugAbuse Sciences Inc. (Aug 16, 2000)
Adolor Corp.
ADVENTRX Pharmaceuticals Inc.
- CA-San Diego-6725 Mesa Ridge Road Lease - Casey Family Trust and ADVENTRX Pharmaceuticals Inc. (Jun 3, 2004)
- Employee Leasing Contract - Biokeys Pharmaceuticals Inc. and Steven M. Plumb, P.C. (Jan 20, 2003)
- Employment Agreement - ADVENTRX Pharmaceuticals Inc. and Brian M. Culley (Nov 15, 2004)
- Employment Agreement - ADVENTRX Pharmaceuticals Inc. and Carrie E. Carlander (Nov 17, 2004)
- Employment Agreement - ADVENTRX Pharmaceuticals Inc. and Cellia Habita (Mar 1, 2004)
- Employment Agreement - Biokeys Pharmaceuticals Inc. and Joan M. Robbins (Mar 5, 2003)
- Executive Employment Agreement - BioQuest Inc. and Warren C. Lau (Dec 1, 1999)
- License Agreement [Amendment No. 1] - University of Southern California and BioKeys Inc. (Jan 23, 1998)
- Option & License Agreement - University of Southern California and BioKeys Inc. (Aug 17, 2000)
- Option and License Agreement - University of Southern California and Biokeys Inc. (Jan 20, 1998)
- Option and License Agreement [Amendment] - University of Southern California and BioKeys Pharmaceuticals Inc. (Apr 21, 2003)
- Patent and Technology License Agreement - University of Texas, the University of Texas M. D. Anderson Cancer Center and BioQuest Inc. (Jun 14, 1996)
- Patent and Technology License Agreement [Amendment No. 1] - University of Texas, the University of Texas M. D. Anderson Cancer Center and BioKeys Pharameuticals Inc. (Jun 15, 2000)
Affymax Inc.
Agouron Pharmaceuticals Inc.
Albany Molecular Research Inc.
Alkermes Inc.
- Change in Control Employment Agreement - Alkermes Inc. and Richard F. Pops (Dec 19, 2000)
- Development Agreement - Medisorb Technologies International LP and Janssen Pharmaceutica International (Dec 23, 1993)
- Development Agreement [Amendment No. 1] - Medisorb Technologies International LP and Janssen Pharmaceutica International (Dec 23, 1993)
- Development Agreement [Amendment No. 2] - Janssen Pharmaceutica International, Medisorb Technologies International and Alkermes Controlled Therapeutics Inc. II (Mar 8, 1996)
- Development Agreement [Amendment No. 3], Manufacturing and Supply Agreement [Amendment No. 2] and License Agreement [Amendment No. 1] - Janssen Pharmaceutica International, Medisrb Technologies International, Alkermes Controlled Therapeutics Inc. II (Apr 1, 2000)
- Development Agreement [Amendment No. 4] and Manufacturing and Supply Agreement [Amendment No. 1] - Janssen Pharmaceutica International, Medisorb Technologies International and Alkermes Controlled Therapeutics Inc. II (Dec 20, 2000)
- Development and License Agreement - R. W. Johnson Pharmaceutical Research Institute and Alkermes Controlled Therapeutics Inc. (Jan 19, 1998)
- Discontinuation Agreement - Alkermes Inc. and Genentech Inc. (Apr 4, 1999)
- Employment Agreement - Alkermes Inc. and David A. Broecker (Dec 22, 2000)
- Employment Agreement - Alkermes Inc. and Kathryn L. Biberstein (Jan 8, 2003)
- Environmental Indemnity Agreement - Alkermes Inc., Alkermes Controlled Therapeutics Inc. II and Fleet National Bank (Sep 27, 1996)
- License Agreement - Alkermes Controlled Therapeutics Inc. and Genentech Inc. (Apr 14, 1999)
- License Agreement - Medisorb Technologies International LP and Janssen Pharmaceutica Inc. (Feb 13, 1996)
- License Agreement - Medisorb Technologies International LP and Janssen Pharmaceutica International (Feb 21, 1996)
- MA-Cambridge-281 Albany Street - Massachusetts Institute of Technology and Alkermes Inc. (Jul 26, 1993)
- MA-Cambridge-64 Sidney Street Lease - Forest City 64 Sidney Street Inc. and Alkermes Inc. (Oct 26, 2000)
- MA-Cambridge-88 Sidney Street Lease - FC 88 Sidney Inc. and Alkermes Inc. (Oct 26, 2000)
- Manufacture and Supply Agreement - Genentech Inc. and Alkermes Controlled Therapeutics Inc. (Jan 1, 2000)
- Manufacturing and Supply Agreement - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Aug 6, 1997)
- Manufacturing and Supply Agreement [Addendum] - JPI Pharmaceutical International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Aug 1, 2001)
- Manufacturing and Supply Agreement [Amendment No. 4] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. IIs (Jan 10, 2005)
- Manufacturing and Supply Agreement [Amendment] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Dec 21, 2002)
- Manufacturing and Supply Agreement [Amendment] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Dec 16, 2003)
- Manufacturing and Supply Agreement [Amendment] - JPI Pharmaceutica International, Janssen Pharmaceutica Inc. and Alkermes Controlled Therapeutics Inc. II (Dec 22, 2003)
- Master Security Agreement - General Electric Capital Corp. and Alkermes Inc. (Dec 22, 2004)
- Patent License Agreement - Massachusetts Institute of Technology and Advanced Inhalation Research Inc. (Aug 11, 1997)
- Supply and License Agreement - R. W. Johnson Pharmaceutical Research Institute, Janssen Pharmaceutica International and Alkermes Inc. (Jan 19, 1998)
Allergan Ligand Retinoid Therapeutics Inc.
Altana AG
Alza Corp.
Amgen Inc.
Applied Molecular Evolution Inc.
- 2000 Employee Stock Purchase Plan - Applied Molecular Evolution Inc. (Jun 20, 2000)
- CA-San Diego-11095 Flintkote Avenue Lease - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Nov 20, 2000)
- CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 1] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Oct 1, 2002)
- CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 2] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Nov 14, 2002)
- CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 3] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Mar 14, 2003)
- CA-San Diego-11095 Flintkote Avenue Lease [Amendment No. 4] - JBC Sorrento West LLC and Applied Molecular Evolution Inc. (Aug 4, 2003)
- CA-San Diego-3520 Dunhill Street Sublease [Amendment No. 4] - General Atomics and Applied Molecular Evolution Inc. (Sep 23, 2002)
- CA-San Diego-3520 Dunhill Street Sublease [Amendment No. 5] - General Atomics and Applied Molecular Evolution Inc. (Aug 20, 2003)
- CA-San Diego-3520/3550 Dunhill Street Lease - General Atomics and Ixsys Inc. (Jun 1, 1993)
- CA-San Diego-Torrey Hills Commercial Land Purchase and Sale Agreement - Westbrook Torrey Hills LP and Torrey View Phase II LP (Jul 10, 2001)
- CA-San Diego-Torrey Hills Commercial Land Purchase and Sale Agreement [Amendment No. 1] - AME Torrey View LLC and Westbrook Torrey Hills LP (Oct 11, 2001)
- CA-San Diego-Torrey Hills Lease Agreement - AME Torrey View LLC and Applied Molecular Evolution Inc. (Aug 20, 2001)
- Collaboration Agreement - Ixsys Inc. and Bio-Management Inc. (Nov 29, 1999)
- Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jun 5, 2000)
- Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jul 3, 2000)
- Employment Agreement - Applied Molecular Evolution Inc. and James B. Breitmeyer (Nov 20, 2001)
- Employment Agreement - Applied Molecular Evolution Inc. and William L. Respess (Jun 7, 2002)
- Engagement Letter and Compensation Agreement - AME Torrey View LLC and Irving Hughes (May 6, 2002)
- Indemnity Agreement - Applied Molecular Evolution Inc. (Jun 20, 2000)
- Lease - General Electric Capital Corp. and Applied Molecular Evolution Inc. (Sep 24, 2003)
- License Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- License Agreement - Ixsys Inc. and Stuart A. Kauffman (Nov 3, 1994)
- License Agreement - The Scripps Research Institute and Ixsys Inc. (May 20, 1994)
- Loan and Security Agreement - Silicon Valley Bank and Applied Molecular Evolution Inc. (Sep 29, 2003)
- Non-Exclusive License Agreement - Ixsys Inc. and Biosite Diagnostics Inc. (Sep 9, 1998)
- Pledge Agreement - Applied Molecular Evolution Inc. and Torrey View Phase II LP (Mar 4, 2002)
- Research and Assignment and License Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- Secured Promissory Note - Ocean Air Associates LLC and Applied Molecular Evolution Inc. (Mar 4, 2002)
- Selection Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- Selection Agreement [Amendment] - MedImmune Inc. and Applied Molecular Evolution Inc. (Mar 8, 2001)
- Stock Purchase Agreement - Attenuon LLC and Applied Molecular Evolution Inc. (Nov 30, 2000)
- Stock Purchase Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- Warrant to Purchase Stock - Ixsys Inc. and Silicon Valley Bank (Aug 30, 1996)
- Warrant to Purchase Stock - Ixsys Inc. and Silicon Valley Bank (Jun 23, 1997)
AstraZeneca plc
- Asset Purchase Agreement - AstraZeneca AB and NeoSan Pharmaceuticals Inc. (Jul 25, 2001)
- Asset Purchase Agreement [Amendment No. 1] - AstraZeneca AB and aaiPharma LLC (Jul 22, 2003)
- Collaboration Agreement - Maxygen Inc. and Zeneca Ltd. (Jun 18, 1999)
- Interim Supply Agreement [Amendment No. 1] - AstraZeneca LP and aaiPharma LLC (Jul 22, 2003)
- KBI Shares Option Agreement - Astra AB, Merck & Co. Inc. and Merck Holdings Inc. (Jul 1, 1998)
- KBI Supply Agreement - Astra Merck Inc. and Astra Pharmaceuticals LP (Jul 1, 1998)
- KBI-E Asset Option Agreement - Astra AB, Merck & Co. Inc., Astra Merck Inc. and Astra Merck Enterprises Inc. (Jul 1, 1998)
- License and Option Agreement - Astra AB and Astra Merck Inc. (Jul 12, 1982)
- Manufacturing Agreement - Merck & Co. Inc., Astra AB, Astra Merck Inc. and Astra USA Inc. (Jul 1, 1998)
- Master Restructuring Agreement - Astra AB, Merck & Co. Inc., Astra Merck Inc., Astra USA Inc., KB USA LP, Astra Merck Enterprises Inc., KBI Sub Inc., Merck Holdings Inc. and Astra Pharmaceuticals LP (Jun 19, 1998)
- Registration Rights Agreement - Maxygen Inc. (Nov 13, 2000)
Aventis
AVI BioPharma Inc.
Axm Pharma Inc.
- Agreement for Processing (OEM) - Shenyang Tianwei Werke Pharmaceutical Co. Ltd. and Qiqihaer No. 2 Pharmaceutical Factory (Sep 19, 2002)
- Agreement on Agency for Sale (Distribution) - Shenyang Tianwei Pharmaceutical Factory and Liaoning Weikang Medicine Co. Ltd. (Mar 30, 2004)
- Consulting Agreement - Axiom Pharmaceuticals Inc. and Amaroq Capital LLC (May 1, 2003)
- Consulting Agreement - Axiom Pharmaceuticals Inc. and Tripoint Capital Advisors LLC (Aug 25, 2003)
- Consulting Agreement - Axm Pharma Inc. and Aston Organization (Feb 2, 2004)
- Consulting Agreement - Madden Consulting Inc. and Axiom Pharmaceuticals Inc. (Apr 3, 2003)
- Corporate Consulting Services - Woodbridge Management Ltd. and Axiom Pharmaceuticals Inc. (Jun 27, 2003)
- Employment Agreement - Axiom Pharmaceutical Inc. and Peter W. Cunningham (Aug 1, 2003)
- Employment Agreement - Axiom Pharmaceuticals Inc. and Lan Hao (Sep 18, 2003)
- Investment Banking Service Agreement - Axm Pharma Inc. and Great Eastern Securities Inc. (Dec 18, 2003)
Bayer AG
Biogen Idec Inc.
- Agreement and Plan of Merger - IDEC Pharmaceuticals Corp. and Biogen Inc. (Jun 20, 2003)
- Antegren Development and Marketing Collaboration Agreement - Biogen Inc. and Elan Pharma International Ltd. (Aug 15, 2000)
- CA-Del Mar-10996 Torreyana Road Lease - 10996 Torreyana Road LP and IDEC Pharmaceuticals Corp. (Jan 17, 2002)
- CA-Oceanside-Ocean Ranch Purchase Agreement and Escrow Instructions - Ivey Ranch Development Co. LLC and IDEC Pharmaceuticals Corp. (Aug 31, 2000)
- CA-San Diego-11011 Torreyana Road Lease Assignment and Asset Purchase Agreement - Tanox West Inc. and Biogen Idec Inc. (Dec 9, 2004)
- CA-San Diego-3030 Callan Road Lease - All Spectrum Services Inc. and IDEC Pharmaceuticals Corp. (Aug 13, 1996)
- CA-San Diego-Nobel Research Park Purchase and Sale Agreement and Escrow Instructions - San Dieguito Partnership LP and IDEC Pharmaceuticals Corp. (Jul 17, 2001)
- Collaboration & License Agreement - Schering AG and IDEC Pharmaceuticals Corp. (Jun 9, 1999)
- Collaborative Development Agreement - Mitsubishi-Tokyo Pharmaceuticals Inc. and IDEC Pharmaceuticals Corp. (Sep 21, 2001)
- Collaborative Development Agreement - Taisho Pharmaceutical Co. Ltd. and IDEC Pharmaceuticals Corp. (Dec 22, 1999)
- Collaborative Development Agreement [Addendum] - Seikagaku Corp. and IDEC Pharmaceuticals Corp. (Mar 22, 2002)
- Collaborative Research and License Agreement - IDEC Pharmaceuticals Corp. and SmithKline Beecham plc (Feb 29, 2000)
- Commercial Supply Agreement - Baxter Pharmaceutical Solutions LLC and IDEC Pharmaceuticals Corp. (Jun 1, 2002)
- Consulting Agreement - Biogen Inc. and Alexander Bearn (Apr 14, 1995)
- Consulting Agreement - Biogen Inc. and Alexander G. Bearn (Mar 24, 1998)
- Employment Agreement - Biogen Inc. and Hans-Peter Hasler (Jun 22, 2001)
- Employment Agreement - Biogen Inc. and Burt Adelman (Apr 2, 1996)
- Employment Agreement - Biogen Inc. and Hans-Peter Hasler (Oct 19, 2001)
- Employment Agreement - Biogen Inc. and Irvin D. Smith (Aug 30, 1993)
- Employment Agreement - Biogen Inc. and James C. Mullen (Mar 18, 1993)
- Employment Agreement - Biogen Inc. and James C. Mullen (Feb 15, 2002)
- Employment Agreement - Biogen Inc. and James C. Mullen (Mar 6, 2003)
- Employment Agreement - Biogen Inc. and James L. Vincent (Mar 10, 2000)
- Employment Agreement - Biogen Inc. and James L. Vincent (Jul 15, 2002)
- Employment Agreement - Biogen Inc. and James R. Tobin (Jan 12, 1994)
- Employment Agreement - Biogen Inc. and Kees Been (Jul 19, 1999)
- Employment Agreement - Biogen Inc. and M. W. Leuchtenberger (Nov 14, 1996)
- Employment Agreement - Biogen Inc. and Mark Leuchtenberger (May 12, 1999)
- Employment Agreement - Biogen Inc. and Peter Kellogg (Jun 21, 2000)
- Employment Agreement - Biogen Inc. and Peter Kellogg (Oct 19, 2001)
- Employment Agreement - Biogen Inc. and Sylvie Gregoire (May 19, 1998)
- Employment Agreement - Biogen Inc. and Sylvie Gregoire (Oct 19, 2001)
- Employment Agreement - Biogen Inc. and Thomas Bucknum (Oct 19, 2001)
- Employment Agreement - Biogen Inc. and Thomas J. Bucknum (Jun 11, 1999)
- Employment Agreement - Biogen Inc. and William Asher (Jul 15, 2002)
- Exclusive License and Development Agreement [Amendment] - Biogen Inc. and Schering Corp. (May 1, 1998)
- Independent Consulting Agreement - Biogen Inc. and Kenneth Murray (Sep 27, 2001)
- Independent Consulting Agreement - Biogen Inc. and Phillip A. Sharp (Dec 15, 1995)
- Independent Consulting Agreement - Biogen Inc. and Phillip A. Sharp (Dec 11, 1998)
- Independent Consulting and Project Agreement - Biogen Inc. and Kenneth Murray (Sep 23, 1995)
- Independent Consulting and Project Agreement - Biogen Inc. and Kenneth Murray (Sep 11, 1998)
- Isotope Agreement - MDS Nordion Inc. and IDEC Pharmaceuticals Corp. (May 14, 1999)
- Isotope Agreement [Amendment No. 3] - MDS (Canada) Inc. and IDEC Pharmaceuticals Corp. (Nov 12, 2001)
- License Agreement - Biogen Inc. and Tanox Biosystems Inc. (Jun 1, 1998)
- License Agreement - Taisho Pharmaceutical Co. Ltd. and IDEC Pharmaceuticals Corp. (Dec 22, 1999)
- Netherlands-Lijnden-Tokyostraat 27-33 Lease - TUG Vastgoed BV and Biogen Idec BV (Jul 2003)
- Stock Option Agreement - Biogen Inc. and James L. Vincent (Sep 22, 1995)
- Stock Option Agreement - Biogen Inc. and James L. Vincent (Dec 12, 1997)
- Supply Agreement - Catalytica Pharmaceuticals Inc. and IDEC Pharmaceuticals Corp. (Aug 2001)
Biopure Corp.
- 1998 Stock Option Plan - Biopure Corp.
- 2002 Omnibus Securities and Incentive Plan - Biopure Corp. (Apr 2, 2003)
- Agency Agreement - Biopure Corp. and The Butler Co. (Mar 29, 1999)
- Agreement - Moyer Packing Co. and Biopure Corp. (Oct 21, 1994)
- Agreement Concerning Sale of Common Stock - Biopure Corp. and Carl W. Rausch (Aug 27, 2003)
- Agreement of License Termination, Stock Repurchase and Mutual General Release - Biopure Corp., Biopure Europe Ltd. and B. Braun Melsungen AG (Aug 29, 1997)
- Agreement of Settlement and Mutual General Release - Biopure Corp., Biopure Associates LP and Credit Francais International SA (Dec 19, 1996)
- Assignment and Assumption of Deed of Easement - Moyer Packing Co. and Biopure Corp. (Jun 12, 2001)
- By-Laws - Biopure Corp. (Jun 24, 1999)
- Consulting Agreement - Biopure Corp. and William D. Hoffman (Feb 17, 2000)
- Deferred Compensation Agreement - Biopure Corp. and Carl W. Rausch (Aug 8, 1990)
- Deferred Compensation Agreement - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
- Distribution Agreement - Network Healthcare Holdings Ltd. and Biopure Corp. (2000)
- Distribution Agreement [Amendment] - Network Healtcare Holdings Ltd., Tshepo Pharmaceuticals (Pty) Ltd. and Biopure Corp. (Mar 9, 2001)
- Employment Agreement - Biopure Corp. (1999)
- Employment Agreement - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
- Employment Agreement - Biopure Corp. and Daniel R. Davis (Dec 3, 1998)
- Employment Agreement - Biopure Corp. and Paul A. Looney (Jun 9, 1999)
- Employment Agreement - Biopure Corp. and Ronald F. Richards (Feb 12, 2003)
- Employment Agreement - Biopure Corp. and Thomas A. Moore (Jun 2002)
- Equity Line Financing Agreement - Biopure Corp. and Societe Generale (Jun 21, 2001)
- Escrow Agreement - B. Braun Melsungen AG, Biopure Corp. and State Street Bank and Trust Co. (Sep 2, 1997)
- Incentive Compensation Plan - Biopure Corp.
- Incentive Compensation and Company Stock Purchase Plan - Biopure Corp.
- License Agreement for Spur Facility - Moyer Packing Co. and Biopure Corp. (Jun 12, 2001)
- License Agreement for Waste Disposal System - Moyer Packing Co. and Biopure Corp. (Jun 12, 2001)
- Loan Agreement - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
- Lock-Up Agreement - Biopure Corp. and C. Everett Koop (Aug 1, 2003)
- Lock-Up Agreement - Biopure Corp. and Charles A. Sanders (Aug 1, 2003)
- Lock-Up Agreement - Biopure Corp. and David N. Judelson (Aug 4, 2003)
- Lock-Up Agreement - Biopure Corp. and Thomas A. Moore (Aug 4, 2003)
- MA-Cambridge-11 Hurley Street Lease - Eleven Hurley Street Associates and Biopure Corp. (Aug 29, 1994)
- MA-Cambridge-22 Spring Street Lease - Torvis Realty Trust and Biopure Corp. (Oct 12, 1990)
- MA-Cambridge-31/35 Hurley Street Lease - Tarvis Realty Trust and Biopure Corp. (May 10, 1994)
- MA-Cambridge-37/39 Hurley Street - Tarvis Realty Trust and Biopure Corp. (Aug 23, 1994)
- MA-Cambridge-58 Charles Street Sublease - Cendant Operations Inc. and Biopure Corp. (Jun 20, 2001)
- MA-Cambridge-84/86 Second Street Lease - Karpowicz Family Trust and Biopure Corp. (May 23, 1997)
- MA-Cambridge-Hurley Street Mortgage - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
- MA-Cambridge-Spring Street Mortgage - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
- NH-Dover-4 Progress Drive Lease Agreement - New England Innovations Corp. and Biopure Corp. (Mar 31, 1995)
- PA-Franconia Lease - Moyer Packing Co. and Biopure Corp. (Oct 21, 1994)
- PA-Franconia Mortgage - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
- Patent Security Agreement - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
- Placement Agency Agreement - Biopure Corp. and Shoreline Pacific LLC (Apr 18, 2002)
- Placement Agency Agreement - DP Securities Inc. and Biopure Corp. (May 1, 2002)
- Placement Agent's Warrant - Biopure Corp. and DP Securities Inc. (May 9, 2002)
- Placement Agent's Warrant - Biopure Corp. and Shoreline Pacific LLC (Apr 23, 2002)
- Promissory Note - Biopure Corp. and Bing L. Wang (Jul 31, 1995)
- Promissory Note - Biopure Corp. and Brian A. Lajoie (Jul 31, 1995)
- Promissory Note - Biopure Corp. and Carl W. Rausch (Jul 29, 2002)
- Promissory Note - Biopure Corp. and Edward E. Jacobs Jr. (Jul 31, 1995)
- Promissory Note - Biopure Corp. and Geoffrey Filbey (Jul 31, 1995)
- Promissory Note - Biopure Corp. and James R. Weston (Jul 31, 1995)
- Promissory Note - Biopure Corp. and Maria S. Gawryl (Jul 31, 1995)
- Promissory Note - Biopure Corp. and Maria S. Gawryl (Jul 31, 2000)
- Promissory Note - Biopure Corp. and Pharmacia (Oct 8, 1996)
- Promissory Note [$1,009,772.01.] - Biopure Corp. and Carl W. Rausch (Jul 31, 1995)
- Promissory Note [$216,033.05] - Biopure Corp. and Carl W. Rausch (Jul 31, 1995)
- Purchase Agreement - Biopure Corp. and INPACO Corp. (Aug 28, 1997)
- Registration Rights Agreement - Biopure Corp. and Societe Generale (Jun 21, 2001)
- SC-Sumter Lease - Sumter Realty Group LLC and Biopure Corp. (Dec 24, 2002)
- Security Agreement - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
- Severance Agreement - Biopure Corp. and Paul Looney (Jun 25, 2002)
- Stock Option Agreement - Biopure Corp. and Thomas A. Moore (Jun 25, 2002)
- Stock Purchase Agreement - Biopure Corp. and Geoffrey J. Filbey (May 1, 1999)
- Trademark Security Agreement - Biopure Corp. and Pharmacia & Upjohn Inc. (Oct 8, 1996)
- Underwriting Agreement - Biopure Corp., J.P. Morgan Securities Inc., Salomon Smith Barney Inc. and Adams, Harkness & Hill Inc. (Mar 13, 2000)
- Warrant to Purchase Stock - Biopure Corp. and Network Healthcare Holdings Ltd. (Nov 1, 2000)
- Warrant to Purchase Stock - Biopure Corp. and Scanix Six (Pty) Ltd. (Nov 1, 2000)
BioReliance Corp.
Biosite Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Cambrex Corp.
CancerVax Corp.
- 2000 Stock Incentive Plan - CancerVax Corp.
- 2003 Equity Incentive Award Plan - CancerVax Corp. (2003)
- 2003 Management Incentive Compensation Plan - CancerVax Corp. (2003)
- Agreement and Plan of Merger - CancerVax Corp. and Cell-Matrix Inc. (Jan 8, 2002)
- Bylaws - CancerVax Corp.
- CA-Carlsbad-2110 Rutherford Road Lease - Blackmore Airport Centre and CancerVax Corp. (Aug 31, 2001)
- CA-Marina del Rey-4503 Glencoe Avenue Lease - Spieker Properties LP and John Wayne Cancer Institute (Jul 22, 1999)
- CA-Marina del Rey-4503 Glencoe Avenue Lease [Amendment No. 1] - EOP-Marina Business Center LLC and CancerVax Corp. (Oct 1, 2001)
- CA-Marina del Rey-4503 Glencoe Avenue Lease [Amendment No. 2] - EOP-Marina Business Center LLC and CancerVax Corp. (Sep 4, 2002)
- CA-Marina del Rey-4503 Glencoe Avenue Lease [Assignment] - John Wayne Cancer Institute and CancerVax Corp. (Aug 4, 2000)
- CDL Agreement - Cancer Diagnostics Laboratories Inc. and CancerVax Corp. (Jul 31, 2000)
- CDL Agreement [Amendment No. 1] - Cancer Diagnostic Laboratories inc. and CancerVax Corp. (Dec 15, 2000)
- CDL Agreement [Amendment No. 2] - Cancer Diagnostic Laboratories Inc. and CancerVax Corp. (May 1, 2002)
- Certificate of Incorporation - CancerVax Corp. (Nov 3, 2003)
- Collaboration Agreement - Ixsys Inc. and Bio-Management Inc. (Nov 29, 1999)
- Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jun 5, 2000)
- Collaboration Agreement [Amendment] - Cell Matrix Inc. and Applied Molecular Evolution Inc. (Jul 3, 2000)
- Consulting Agreement - CancerVax Corp. and Donald L. Morton (Dec 15, 2000)
- Contribution of Technology and Exchange Agreement - Donald L. Morton and CancerVax Corp. (Dec 15, 2000)
- Contribution of Technology and Exchange Agreement [Amendment No. 1] - Donald L Morton and CancerVax Corp. (May 1, 2002)
- Cross-License Agreement - CancerVax Inc. and the John Wayne Cancer Institute (Jul 24, 1998)
- Cross-License Agreement [Assignment] - 3DLM Inc., the John Wayne Cancer Institute and CancerVax Corp. (Jul 31, 2000)
- Development and Sublicensing Agreement - Cell-Matrix Inc. and Eyetech Pharmaceuticals Inc. (Mar 5, 2001)
- Employee Stock Purchase Plan - CancerVax Corp.
- Employment Agreement - CancerVax Corp. and David F. Hale (Oct 23, 2000)
- Employment Agreement - CancerVax Corp. and Debra J. Arnold (Feb 1, 2002)
- Employment Agreement - CancerVax Corp. and Dennis Van Epps (Nov 26, 2001)
- Employment Agreement - CancerVax Corp. and Guy Gammon (Jan 1, 2001)
- Employment Agreement - CancerVax Corp. and Hazel M. Aker (Feb 9, 2001)
- Employment Agreement - CancerVax Corp. and John Petricciani (Jan 5, 2001)
- Employment Agreement - CancerVax Corp. and Martin A. Mattingly (May 15, 2003)
- Employment Agreement - CancerVax Corp. and Robert L. Jones (Jan 15, 2001)
- Employment Agreement - CancerVax Corp. and William R. LaRue (Apr 2, 2001)
- Employment Agreement [Amendment No. 1] - CancerVax Corp. and David F. Hale (Apr 29, 2003)
- Fetal Antigen License Agreement - Donald L. Morton and CancerVax Corp. (Dec 15, 2000)
- Indemnification Agreement - CancerVax Corp. (2003)
- Letter Agreement - CancerVax Corp., the John Wayne Cancer Institute and Synteract Inc. (Jan 22, 2002)
- License Agreement - M-Tech Therapeutics Inc. and CancerVax Corp. (Oct 4, 2002)
- License Agreement - New York University and Cell-Matrix Inc. (Jun 2, 2003)
- License Agreement - Scripps Research Institute and Cell Matrix Inc. (2001)
- License Agreement - University of Southern California and Bio-Management Inc. (Sep 19, 1999)
- License Agreement - University of Southern California and Bio-Management Inc. (May 23, 2000)
- Loan and Security Agreement - CancerVax Corp. and Venture Lending & Leasing III Inc. (Sep 6, 2002)
- Master Services Agreement - CancerVax Corp., the John Wayne Cancer Institute and Synteract Inc. (Jan 22, 2002)
- Stockholders' Agreement - CancerVax Corp., the Morton Family Trust, the Morton Annuity Trust, OncoVac Inc. and the John Wayne Cancer Institute (Aug 13, 2003)
- Supply Agreement - Organon Teknika Corp. and CancerVax Inc. (Apr 15, 1998)
- Supply Agreement [Assignment] - 3DLM Inc. and CancerVax Corp. (Jul 31, 2000)
Celgene Corp.
- Agreement - Celgene Corp., Children's Medical Center Corp., Bioventure Investments kft and EntreMed Inc. (Aug 2001)
- Collaborative Research and License Agreement - Novartis Pharma AG and Celgene Corp. (Dec 20, 2000)
- Custom Manufacturing Agreement - Johnson Matthey Inc. and Celgene Corp. (Jun 1, 2000)
- Development and License Agreement - Celgene Corp. and Novartis Pharma AG (Apr 19, 2000)
- Distribution Services Agreement - Celgene Corp. and Ivers Lee Corp. d/b/a Sharp (Jun 2000)
- Distribution and Supply Agreement - Smithkline Beecham Corp. d/b/a GlaxoSmithKline and Celgene Corp (Mar 31, 2003)
- Employment Agreement - Celgene Corp. and John W. Jackson (Jan 1, 2000)
- Employment Agreement - Celgene Corp. and Robert J. Hugin (Jan 1, 2000)
- Employment Agreement - Celgene Corp. and Sol J. Barer (Jan 1, 2000)
- Exclusive License Agreement - Celgene Corp., Children's Medical Center Corp. and EntreMed Inc. (Dec 31, 2002)
- License Agreement - EntreMed Inc. and Celgene Corp. (Dec 9, 1998)
- Manufacturing and Supply Agreement - Celgene Corp. and Mikart Inc. (Apr 11, 2001)
- Securities Purchase Agreement - Pharmion Corp. and Celgene Corp. (Apr 8, 2003)
- Supply Agreement - Siegfried (USA) Inc. and Celgene Corp. (Jan 1, 2003)
- Supply Agreement - Sifavitor spa and Celgene Corp. (Sep 28, 1999)
Cell Genesys Inc.
Celltrion Inc.
Centocor Inc.
Cerus Corp.
- CA-Concord-2341 Stanwell Drive Lease - Holmgren Partners and Steritech Inc. (Feb 1, 1996)
- CA-Concord-2401 Stanwell Drive Lease - Cuff Trust and Steritech Inc. (Apr 29, 1982)
- CA-Concord-2411 Stanwell Drive Lease - Redwoods Office Center LP and Cerus Corp. (Dec 17, 1999)
- CA-Concord-2525 Stanwell Drive Lease - Shamrock Development Co. and Steritech Inc. (Oct 1, 1992)
- CA-Concord-2550 Stanwell Drive Lease - California Development Inc. and Cerus Corp. (Oct 12, 2001)
- Collaboration and License Agreement - Cerus Corp. and MedImmune Inc. (Apr 20, 2004)
- Collaborative License Agreement - Cerus Corp. and Kirin Brewery Co. Ltd. (Dec 31, 2000)
- Custom Synthesis Agreement - Steritech Inc. (Mar 14, 1996)
- Development, Manufacturing and Marketing Agreement - Baxter Healthcare Corp. and Steritech Inc. (Dec 13, 1993)
- Development, Manufacturing and Marketing Agreement - Baxter Healthcare Corp. and Steritech Inc. (Apr 1, 1996)
- Employment Agreement - Cerus Corp. and Claes Glassell (Aug 2, 2004)
- Employment Agreement - Cerus Corp. and Howard Ervin (May 28, 1999)
- License Agreement - Steritech Inc., Miles Inc. and Diamond Scientific Corp. (Nov 30, 1992)
- Research, Development, Reduction to Practice and Manufacturing Contract - Cerus Corp. (Oct 1, 1996)
- Supply Agreement - Steritech Inc. (Jul 18, 1994)
Chiron Corp.
- Asset Purchase Agreement - Chiron Diagnostics Corp., Chiron Corp. and Bio-Rad Laboratories Inc. (Dec 5, 1997)
- License Agreement - BioMedicines Inc. and Chiron Corp. (Nov 7, 2002)
- License Agreement - Cubist Pharmaceuticals Inc. and Chiron Healthcare Ireland Ltd. (Oct 2, 2003)
- License Agreement [Amendment No. 1] - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Apr 1, 2004)
- Manufacturing Services Agreement - Chiron Corp. and EntreMed Inc. (Apr 13, 2000)
- Manufacturing and Supply Agreement - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Oct 2, 2003)
- Research and Development License and Options for Commercial License - PanGenetics BV, Panorama Research Inc., Mark de Boer and Chiron Corp. (Sep 25, 1995)
Covance Inc.
Cubist Pharmaceuticals Inc.
- Agreement - Albany Molecular Research Inc. and Cubist Pharmaceuticals Inc. (Jul 30, 2001)
- Assignment and License Agreement - Eli Lilly & Co. and Cubist Pharmaceuticals Inc. (Oct 6, 2000)
- Assignment and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Eli Lilly and Co. (Jul 1, 2003)
- Audit Committee Charter - Cubist Pharmaceuticals Inc.
- Clinical Services Master Agreement - Cubist Pharmaceuticals Inc. and IBAH Inc. (Dec 1, 1999)
- Collaboration Agreement - Cubist Pharmaceuticals Inc. and Syrrx Inc. (Jun 27, 2001)
- Collaborative Research and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 4, 2002)
- Collaborative Research and License Agreement - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 3, 1999)
- Collaborative Research and License Agreement [Amendment No. 1] - Merck & Co. Inc. and Cubist Pharmaceuticals Inc. (Oct 30, 1997)
- Collaborative Research and License Agreement [Amendment No. 2] - Merck & Co. Inc. and Cubist Pharmaceuticals Inc. (Apr 30, 1998)
- Compound Library Screening Agreement - Genzyme Corp. and Cubist Pharmaceuticals Inc. (Feb 24, 1997)
- Contract Research Agreement - Target Research Associates Inc. and Cubist Pharmaceuticals Iinc. (Aug 1, 2000)
- Contract of Monitoring Services - Cubist Pharmaceuticals Inc. and Clindev (Pty) Ltd. (Jan 10, 2000)
- Credit Agreement - Cubist Pharmaceuticals Inc. and Citizens Bank of Massachusetts (Apr 30, 2003)
- Development and Supply Agreement - Cubist Pharmaceuticals Inc. and Abbott Laboratories (Apr 3, 2000)
- Employee Confidentiality Agreement - Cubist Pharmaceuticals Inc.
- Employment Agreement - Cubist Pharmaceuticals Inc. and Barry I. Eisenstein (Jan 20, 2003)
- Employment Agreement - Cubist Pharmaceuticals Inc. and Christopher D. T. Guiffre (Jan 20, 2003)
- Employment Agreement - Cubist Pharmaceuticals Inc. and David W. J. McGirr (Jan 20, 2003)
- Employment Agreement - Cubist Pharmaceuticals Inc. and Francis P. Tally (Jan 20, 2003)
- Employment Agreement - Cubist Pharmaceuticals Inc. and Michael W. Bonney (Jan 20, 2003)
- Employment Agreement - Cubist Pharmaceuticals Inc. and Oliver Fetzer (Jan 20, 2003)
- Employment Agreement - Cubist Pharmaceuticals Inc. and Scott M. Rocklage (Feb 25, 2003)
- Incentive Stock Option Agreement - Cubist Pharmaceuticals Inc. and Mark P. Carthy (May 19, 1997)
- Library Sample Evaluation Agreement - Pharmacopeia Inc. and Cubist Pharmaceuticals Inc. (Sep 11, 1996)
- License Agreement - Cubist Pharmaceuticals Inc. and Biochemie GmbH (Jul 31, 2002)
- License Agreement - Cubist Pharmaceuticals Inc. and Chiron Healthcare Ireland Ltd. (Oct 2, 2003)
- License Agreement - Cubist Pharmaceuticals Inc. and University of Utah (Dec 27, 2001)
- License Agreement - Cubist Pharmaceuticals Inc. and XTL Biopharmaceuticals Ltd. (Jun 2, 2004)
- License Agreement - Eli Lilly & Co. and Cubist Pharmaceuticals Inc. (Nov 7, 1997)
- License Agreement - International Health Management Associates Inc. and Cubist Pharmaceuticals Inc. (Nov 22, 2000)
- License Agreement [Addendum No. 1] - International Health Management Associates Inc. and Cubist Pharmaceuticals Inc. (Feb 28, 2003)
- License Agreement [Amendment No. 1] - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Apr 1, 2004)
- License Agreement [Amendment No. 1] - Cubist Pharmaceuticals inc. and Sandoz GmbH (Jul 16, 2003)
- MA-Lexington-45/55 Hayden Avenue Lease - California State Teachers' Retirement System and Cubist Pharmaceuticals Inc. (Aug 1, 2004)
- MA-Lexington-65 Hayden Avenue Purchase and Sale Agreement - Spaulding and Slye Hayden Woods LLC and Cubist Pharmaceuticals Inc. (Jul 28, 2000)
- Manufacturing and Supply Agreement - ACS Dobfar SpA and Cubist Pharmaceuticals Inc. (Sep 30, 2001)
- Manufacturing and Supply Agreement - Chiron Healthcare Ireland Ltd. and Cubist Pharmaceuticals Inc. (Oct 2, 2003)
- Manufacturing and Supply Agreement - DSM Capua SpA and Cubist Pharmaceuticals Inc. (Jun 22, 2000)
- Manufacturing and Supply Agreement [Amendment No. 2] - ACS Dobfar SpA and Cubist Pharmaceuticals Inc. (Feb 12, 2003)
- Marketing, Distribution and Development Agreement - Gilead Sciences Inc. and Cubist Pharmaceuticals Inc. (Jan 6, 2001)
- Master Lease Agreement - Transamerica Business Credit Corp. and Cubist Pharmaceuticals Inc. (Feb 7, 1997)
- Master Services Agreement - Cubist Pharmaceuticals Inc. and Quintiles Inc. (Apr 25, 2001)
- Memorandum of Understanding - DSM Fine Chemicals Netherlands BV and Cubist Pharmaceuticals Inc. (Jan 26, 2000)
- Patent Cross-License Agreement - Terragen Discovery Inc. and Diversa Corp. (Nov 18, 1999)
- Research Collaboration and License Agreement - ArQule Inc. and Cubist Pharmaceuticals Inc. (Oct 22, 1997)
- Research Collaboration and License Agreement - Cubist Pharmaceuticals Inc. and Novalon Pharmaceutical Corp. (May 5, 1997)
- Research and Development Collaboration and Option Agreement - Emisphere Technologies Inc. and Cubist Pharmaceuticals Inc. (Sep 2000)
- Restricted Stock Agreement - Cubist Pharmaceuticals Inc. and Alan D. Watson (Sep 25, 1999)
- Screening Service Agreement - Cetek Corp. and Cubist Pharmaceuticals Inc. (Dec 7, 2001)
- Secured Promissory Note - Cubist Pharmaceuticals Inc. and Alan D. Watson (Sep 25, 1999)
- Secured Promissory Note - Cubist Pharmaceuticals Inc. and Mark P. Carthy (May 19, 1997)
- Services Agreement - Gist-brocades Holding AG and Cubist Pharmaceuticals Inc. (Jun 22, 2000)
- Stock Pledge Agreement - Cubist Pharmaceuticals Inc. and Alan D. Watson (Sep 25, 1999)
- Stock Purchase Agreement - Novartis Pharma AG and Cubist Pharmaceuticals Inc. (Feb 1999)
- UK-Berkshire-Slough-Trading Estate-250 Bath Road Lease - Slough Trading Estate Ltd., Cubist Pharmaceuticals (UK) Ltd. and Cubist Pharmaceuticals Inc. (Feb 20, 2002)
- Work Order - Cubist Pharmaceuticals Inc. and Quintiles Inc. (Jun 7, 2001)
CytRx Corp.
- Agreement and Plan of Merger - CytRx Corp. and Global Genomics Capital Inc. (Feb 11, 2002)
- Agreement of Settlement and Release - CytRx Corp., Corporate Capital Group International Ltd. and Peter Simone (Aug 8, 2003)
- Asset Purchase Agreement - Proceutics Inc. and Oread Laboratories Inc. (Feb 10, 1998)
- Change In Control Employment Agreement - CytRx Corp. and Jack J. Luchese (Apr 16, 1997)
- Change In Control Employment Agreement - CytRx Corp. and Jack J. Luchese (Sep 1, 1999)
- Change in Control Employment Agreement [Amendment No. 1] - CytRx Corp. and Jack J. Luchese (Jan 1, 2002)
- Common Stock Purchase Agreement - CytRx Corp., Celeste Trust Reg., AMRO International SA and Balmore Funds SA (Mar 24, 2000)
- Consulting/Engagement Agreement - Corporate Capital Group International Inc. and CytRx Corp. (Feb 21, 2003)
- Employment Agreement - Araios Inc. and Mark A. Tepper (Sep 17, 2003)
- Employment Agreement - CytRx Corp. and C. Kirk Peacock (Aug 1, 2003)
- Employment Agreement - CytRx Corp. and Jack J. Luchese (Mar 1995)
- Employment Agreement - CytRx Corp. and Jack J. Luchese (Sep 1, 1999)
- Employment Agreement - CytRx Corp. and Steven A. Kriegsman (May 2002)
- Employment Agreement - CytRx Corp. and Steven A. Kriegsman (Jun 10, 2003)
- Employment Agreement [Amendment No. 1] - CytRx Corp. and Jack J. Luchese (Apr 16, 1997)
- Employment Agreement [Amendment No. 1] - CytRx Corp. and Jack J. Luchese (Jan 1, 2002)
- Engagement Agreement - Cappello Capital Corp. and CytRx Corp. (Jan 1, 2002)
- Engagement Letter - CytRx Corp. and Cappello Capital Corp. (May 16, 2003)
- Engagement Letter - CytRx Corp. and Cappello Capital Corp. (Sep 19, 2003)
- Engagement Letter - CytRx Corp. and Cardinal Securities LLC (May 27, 2003)
- Engagement Letter - CytRx Corp. and Sands Brothers & Co. Ltd. (Sep 12, 2002)
- Engagement Letter [Amendment] - CytRx Corp. and Cardinal Securities LLC (Jun 6, 2003)
- Financial Consulting Agreement - CytRx Corp. and James Skalko (May 10, 2003)
- GA-Norcross-150 Technology Parkway Lease - Proceutics Inc. and Oread Inc. (Feb 1998)
- GA-Norcross-150 Technology Parkway Sublease - Oread Inc. and CytRx Corp. (Feb 16, 1998)
- Independent Contractor Agreement - CytRx Corp. and Louis J. Ignarro (Jul 17, 2003)
- Investment Banking Agreement - CytRx Corp. and J.P. Turner & Co. LLC (Apr 3, 2003)
- Investment Banking Agreement - CytRx Corp. and Rockwell Asset Management Inc. (Apr 1, 2003)
- Investment Banking Agreement [Amendment No. 1] - CytRx Corp. and J.P. Turner & Co. LLC (Apr 3, 2003)
- Investment Banking Agreement [Amendment No. 2] - CytRx Corp. and J.P. Turner & Co. LLC (Apr 3, 2003)
- License Agreement - CytRx Corp. and Ivy Animal Health Inc. (Feb 16, 2001)
- License Agreement - University of Massachusetts and CytRx Corp. (Sep 15, 2003)
- Marketing Agreement - Madison & Wall Worldwide Inc. and CytRx Corp. (Aug 14, 2002)
- Office Space Agreement - Kriegsman Capital Group LLC and CytRx Corp. (Feb 11, 2002)
- Option Agreement - PSMA Development Co. LLC and CytRx Corp. (Dec 23, 2002)
- Placement Agent Agreement - CytRx Corp. and Dunwoody Brokerage Services Inc. (Sep 15, 2003)
- Placement Agent Agreement - CytRx Corp. and Gilford Securities Inc. (Sep 15, 2003)
- Preferred Stock Purchase Agreement - Araios Inc. and CytRx Corp. (Sep 16, 2003)
- Private Placement Agent Agreement - CytRx Corp. and Maxim Corp. LLC (Sep 16, 2003)
- Professional Services Agreement - CytRx Corp., The Kriegsman Group and Kriegsman Capital Group (Jan 29, 2003)
- Stockholders Agreement - Araios Inc. and CytRx Corp. (Sep 17, 2003)
- Supply Agreement - CytRx Corp. and Nycomed Inc. (Aug 30, 1999)
Daiichi Pharmaceutical Corp.
deCODE genetics Inc.
- 2002 Equity Incentive Plan - deCODE genetics Inc. (Aug 30, 2002)
- Agreement - University of Iceland, Islensk Erfdagreining ehf. and the City of Reykjavik (Feb 15, 2000)
- Agreement Relating to the Issue of an Operating Licence for the Creation and Operation of a Health Sector Database - Minister for Health and Social Security and Islensk Erfdagreining ehf. (Jan 21, 2000)
- Agreement on the Creation of a Database of Icelandic Genealogy - Fridrik Skulason and Islensk Erfdagreining (Apr 15, 1997)
- Agreement on the Details of the Arrangement of Encumbrances in the Site Agreement - University of Iceland, Islensk Erfoagreining ehf. and the City of Reykjavik (Feb 15, 2000)
- Agreement on the Details of the Arrangement of Encumbrances in the Site Agreement [Annex] - University of Iceland, Islensk erfoagreining ehf. and the City of Reykjavik (Jan 4, 2002)
- Agreement on the Sale and Listing of Bonds - Islandsbanki FBA hf. and Islensk Erfoagreining ehf. (Dec 21, 2001)
- Co-operation Agreement - Akureyri Central Hospital and Islensk Erfdagreining ehf. (Oct 26, 1999)
- Co-operation Agreement - Reykjavik Hospital and Islensk Erfdagreining ehf. (Nov 4, 1998)
- Co-operation Agreement - The Icelandic State Hospital and Islensk Erfdagreining ehf. (Dec 15, 1998)
- Collaboration Agreement - Collaborative Group on Alzheimer's Disease and Related Disorders and Islensk Erfdagreining ehf. (Jul 19, 1998)
- Collaboration Agreement - Genmab A/S, Medarex Inc., Genpharm International Inc. and deCODE genetics ehf. (Jun 12, 2001)
- Collaboration Agreement - Helgi Jonsson, Thorvaldur Ingvarsson and Islensk Erfdagreining ehf. (Mar 31, 1998)
- Collaboration Agreement - The Icelandic Heart Association, Hjartavernd and Islensk Erfdagreining ehf. (Feb 13, 1998)
- Collaboration Agreement - The Research Group on Arterial Hypertension and Islensk Erfdagreining ehf. (Jun 3, 1998)
- Collaboration Agreement - The Research Group on Osteoporosis and Islensk Erfdagreining ehf. (Jul 19, 1998)
- Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd. AG and deCODE genetics ehf. (Jun 29, 2001)
- Consultancy Contract - deCODE genetics Inc. and Vane Associates (Dec 1, 1997)
- Consultancy Contract - deCODE genetics Inc. and Vane Associates (Aug 30, 2002)
- Contract Services Agreement - Encode ehf. and Genmab A/S (Jun 12, 2001)
- Contract on Financial Leasing - Lysing hf and Islensk Erfdagreining ehf. (Jun 19, 1998)
- Contract on Financial Leasing - Lysing hf. and Islensk Erfoagreining ehf. (Dec 31, 2001)
- Contract on the Processing of Clinical Data and Their Transfer to a Health Sector Database - Islensk Erfoagreining ehf.
- Crosswalk Development Agreement - Partners HealthCare System Inc., The General Hospital Corporation d/b/a Massachusetts General Hospital, The Brigham and Women's Hospital Inc. and deCODE genetics Ltd. (May 11, 2000)
- Currency Swap Agreement - Sturlugata 8 ehf. and Islandsbanki-FBA hf. (Dec 27, 2001)
- Currency Swap Agreement - Vetrargarourinn ehf. and Islandsbanki-FBA hf. (Mar 13, 2002)
- Directorship Agreement - deCODE genetics Inc. and J. Neal Armstrong (Aug 18, 2003)
- Employee Confidentiality, Invention Assignment and Non-Compete Agreement - deCODE genetics Inc. and C. Augustine Kong (Jan 1, 2001)
- Employee Confidentiality, Invention Assignment and Non-Compete Agreement - deCODE genetics Inc. and Lance Thibault (Feb 1, 2001)
- Employee Confidentiality, Invention Assignment and Non-Compete Agreement - deCODE genetics Inc. and Mark Gurney (Aug 21, 2000)
- Employment Agreement - deCODE genetics Inc. and Chung Tung Augustine Kong (Dec 30, 2000)
- Employment Agreement - deCODE genetics Inc. and Michael W. Young (Jun 4, 2001)
- Employment Agreement - deCODE genetics Ltd. and Einar Stefansson (Nov 22, 2000)
- Employment Agreement - deCODE genetics ehf. and Hakon Guobjartsson (May 5, 1999)
- Employment Contract - Islensk Erfdagreining ehf. and Sigurdur Ingibergur Bjornsson (Jan 15, 1999)
- Employment Contract - Islensk Erfoagreining ehf. and Hakon Hakonarson (Jul 23, 2003)
- Employment Contract - deCODE genetics ehf. and Axel Nielsen (Jul 1, 1998)
- Employment Contract - deCODE genetics ehf. and Kristjan Erlendsson (Sep 4, 1998)
- Founder Stock Purchase Agreement - deCODE genetics Inc. and Jeffrey R. Gulcher (Aug 21, 1996)
- Iceland-Kopavogur-Hlidarsmari 19 Lease - Computer Centre of the Icelandic Savings Banks and Islensk Erfdagreining ehf. (Nov 24, 1999)
- Iceland-Kopavogur-Hlidarsmari 19 Lease - Fridar sf. and Islensk Erfdagreining ehf. (Feb 18, 1999)
- Iceland-Kopavogur-Hlioarsmari 15 Lease - Veigur ehf and Islensk Erfoagreining hf. (Apr 2000)
- Iceland-Kopavogur-Hlioarsmari 17 Lease - Miojan ehf. and Islensk Erfoagreining ehf. (Mar 1, 2000)
- Iceland-Reykjavik-Lynghals 1 Contract on Sale and Leaseback - The Icelandic Investment Bank and Islensk Erfdagreining ehf. (Jun 8, 1998)
- Iceland-Reykjavik-Sturlugata No. 8 Lease - Islensk Erfoagreining ehf., University of Iceland and the City of Reykjavik (Oct 3, 2000)
- Indemnity Agreement - deCODE genetics Inc. and John Vane (Dec 1, 1997)
- Joint Development and Commercialization Agreement - deCODE genetics ehf. and PE Corp. (Jul 16, 2001)
- License Agreement - Islensk Erfdagreining ehf.
- Loan Agreement - Islandsbanki-FBA hf. and Sturlugata 8 ehf. (Dec 21, 2001)
- Loan Agreement - Islandsbanki-FBA hf. and Sturlugata 8 ehf. (Dec 27, 2001)
- Loan Agreement - Islensk Erfoagreining ehf. and Kristjan Erlendsson (Oct 15, 2001)
- Loan Agreement - Vetrargarourinn ehf. and Islandsbanki hf. (Mar 13, 2002)
- Non-Recourse Promissory Note - deCODE genetics Inc. and Einar Stefansson (Dec 21, 2000)
- Non-Recourse Promissory Note - deCODE genetics Inc. and Hakon Guobjartsson (Jan 29, 1998)
- Non-Recourse Promissory Note - deCODE genetics Inc. and Hannes T. Smarason (Mar 24, 1999)
- Non-Recourse Promissory Note - deCODE genetics Inc. and Hannes T. Smarason (Sep 15, 1999)
- Non-Recourse Promissory Note - deCODE genetics Inc. and Hannes T. Smarason (Jan 1, 2001)
- Non-Recourse Promissory Note - deCODE genetics Inc. and Sigurdur I. Bjornsson (Mar 24, 1999)
- Non-Statutory Stock Option Agreement - deCODE genetics Inc.
- Operating License for the Creation and Operation of a Health Sector Database - Minister for Health and Social Security and Islensk Erfdagreining ehf (Jan 22, 2000)
- Pharmacogenomics Collaboration and License Agreement - Encode ehf. and Affymetrix Inc. (Jul 16, 2001)
- Promissory Note - deCODE genetics Inc. and Hakon Gudbjartsson (May 27, 2002)
- Property Lien - Sturlugata 8 ehf. and Islandsbanki-FBA hf. (Dec 21, 2001)
- Property Lien - Vetrargarourinn ehf. and Islandsbanki-FBA hf. (Feb 28, 2002)
- Reagent Supply Agreement - deCODE genetics ehf. and PE Corp. (Jul 16, 2001)
- Research Agreement - Rannsokna-og Fredsluejodurinn ehf and deCODE genetics Inc. (Oct 24, 1997)
- Research Collaboration Agreement - Islenskar Hveraorverur ehf. and Islensk Erfdagreining ehf. (Dec 28, 1999)
- Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics Inc. (Feb 1, 1998)
- Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics ehf. (Feb 1, 2002)
- Research Collaboration and License Agreement - deCODE genetics Inc., deCODE genetics ehf. and Merck & Co. Inc. (Sep 26, 2002)
- Research Contract - Research Team for Age-Related Macular Degeneration and Islensk Erfdagreining ehf. (Apr 27, 1999)
- Research Contract - Research Team for Allergy and Asthma and Islensk Erfdagreining ehf. (Aug 20, 1999)
- Research Contract - Research Team for Cerebral Haemorrhage and Islensk Erfdagreining ehf. (Nov 3, 1999)
- Research Contract - Research Team for Chronic Obstructive Pulmonary Disease and Islensk Erfoagreining ehf. (Aug 20, 1999)
- Research Contract - Research Team for Epidemiology and Heredity of Lung Cancer and Islensk Erfoagreining ehf. (Jun 29, 2000)
- Research Contract - Research Team for Peripheral Artery Occlusive Disease and Islensk Erfdagreining ehf. (May 28, 1999)
- Settlement Agreement - The Beth Israel Deaconess Medical Center and deCODE genetics Inc. (Dec 31, 1997)
- Stock Purchase Agreement - Islensk Erfoagreining ehf., Kace Traders Ltd., Einar Stefansson and Thorsteinn Loftsson (Nov 8, 2000)
- Stock and Warrant Purchase Agreement - Roche Finance Ltd. and deCODE genetics Inc. (Feb 1, 1998)
- Strategic Alliance Agreement - Partners Healthcare System Inc., The General Hospital Corporation d/b/a Massachusetts General Hospital, The Brigham and Women's Hospital Inc. and deCODE genetics Ltd. (May 11, 2000)
- Work Contract - Islensk Erfdagreining ehf. and Eykt ehf. (Mar 15, 2001)
Delcath Systems Inc.
diaDexus Inc.
Diversa Corp.
- Asset Sale Agreement - Diversa Corp. and Glaxo Wellcome SA (Jul 18, 2003)
- CA-San Diego-10655/10665/10675 Sorrento Valley Road Lease - Sycamore/San Diego Investors and Recombinant BioCatalysis Inc. (Sep 24, 1996)
- CA-San Diego-Sorrento Gateway Building A Lease - KR-Gateway Partners and Diversa Corp. (Feb 11, 2000)
- CA-San Diego-Sorrento Gateway Building B Lease - KR-Gateway Partners and Diversa Corp. (Feb 11, 2000)
- Collaboration Agreement - Glaxo Research and Development Ltd., Glaxo Group Ltd. and Diversa Corp. (Dec 8, 2000)
- Collaboration Agreement - Novartis Agribusiness Biotechnology Research Inc. and Diversa Corp. (Jan 25, 1999)
- Collaboration Agreement - Rhone-Poulenc Animal Nutrition SA and Diversa Corp. (Jun 28, 1999)
- Collaborative DNA Sequencing Agreement - Diversa Corp. and PE Corp. (NY) (Dec 1, 2000)
- Collaborative Research Agreement - Dow Chemical Co. and Diversa Corp. (Jul 22, 1999)
- Drug Discovery, Development, and License Agreement - Diversa Corp. and IntraBiotics Pharmaceuticals Inc. (Jan 6, 2001)
- Employment Agreement - Diversa Corp. and Jay M. Short (Jun 25, 1998)
- Employment Agreement - Diversa Corp. and Karin Eastham (Apr 2, 1999)
- Employment Agreement - Diversa Corp. and William H. Baum (Jul 31, 1997)
- Employment Agreement - Industrial Genome Sciences and Jay Short (Aug 30, 1994)
- Employment Agreement - Recombinant Biocatalysis Inc. and R. Patrick Simms (Feb 3, 1997)
- Joint Venture Agreement - Diversa Corp. and Novartis Seeds AG (Dec 1, 1999)
- License Agreement - Diversa Corp. and Finnfeeds International Ltd. (Dec 1, 1998)
- License Agreement - Dow Chemical Co. and Diversa Corp. (Jul 22, 1999)
- License Agreement - Invitrogen Corp. and Diversa Corp. (Mar 29, 1999)
- License Agreement - New Venture LLC and Diversa Corp. (Jun 29, 2000)
- License Agreement [Amendment No. 2] - Mycogen Corp. and Diversa Corp. (Mar 6, 1998)
- Limited Liability Company Agreement - New Venture LLC, Diversa Corp. and Dow Chemical Co. (Jun 29, 2000)
- Master Collaboration Agreement - Diversa Corp. and Dow Chemical Co. (Sep 1, 2000)
- Master Lease Agreement - Diversa Corp. and Transamerica Business Credit Corp. (Apr 13, 1999)
- Patent Cross-License Agreement - Terragen Discovery Inc. and Diversa Corp. (Nov 18, 1999)
- Project Agreement - Dow Chemical Co. and Diversa Corp. (Nov 30, 2000)
- Research Agreement - New Venture LLC and Diversa Corp. (Jun 29, 2000)
- Research Lease - One Cell Systems Inc. and Diversa Corp. (Feb 16, 1999)
- Research and Development Agreement - Novartis Enzymes Inc. and Diversa Corp. (Dec 1, 1999)
- Separation Agreement - Diversa Corp. and Kathleen H. Van Sleen (Mar 15, 1999)
- Separation Agreement - Diversa Corp. and Terrance J. Bruggeman (Feb 4, 1999)
- Stock Purchase Agreement - Diversa Corp. and Novartis Agribusiness Biotechnology Research Inc. (Jan 25, 1999)
DrugAbuse Sciences Inc.
- Agreement - Universite Paris V, DrugAbuse Sciences SAS and DrugAbuse Sciences Inc. (Jun 8, 1999)
- Agreement for The Transfer of Scientific and Technical Knowledge and for The Commercial Exploitation of Research Results - Universite Paris V, DrugAbuse Sciences SAS and DrugAbuse Sciences Inc. (Mar 3, 2000)
- CA-Los Altos-330 Distel Circle Lease - Midpeninsula Regional Open Space District and DrugAbuse Sciences Inc. (Feb 9, 2000)
- CA-Menlo Park-1430 O'Brien Drive Sublease - Menlo Business Park and DrugAbuse Sciences Inc. (Oct 1, 1998)
- Clinical Supply Agreement - DrugAbuse Sciences Inc. and SP Pharmaceuticals LLC (Nov 24, 1999)
- Employment Agreement - DrugAbuse Sciences Inc. and Donald R. Wesson (Oct 18, 1999)
- Employment Agreement - DrugAbuse Sciences Inc. and Elizabeth Greetham (Feb 4, 2000)
- Employment Agreement - DrugAbuse Sciences Inc. and Jacques Kusmierek (Dec 28, 1999)
- Employment Agreement - DrugAbuse Sciences Inc. and James W. Elder (Dec 27, 1999)
- Employment Agreement - DrugAbuse Sciences Inc. and Jason A. Gross (Dec 29, 1999)
- Employment Agreement - DrugAbuse Sciences Inc. and Laurent Chardonnet (Mar 27, 2000)
- Employment Agreement - DrugAbuse Sciences Inc. and Stanley A. Kaplan (Dec 26, 1999)
- Employment Agreement - DrugAbuse Sciences SAS and Maryvonne Hiance (Jun 9, 1999)
- France-Paris-48-50 Rue Boissonnade Lease - Financiere ETS and DrugAbuse Sciences (Feb 1, 2000)
- License Agreement - Abbott Laboratories and DrugAbuse Sciences Inc. (Aug 16, 2000)
- License Agreement - The Scripps Research Institute and DrugAbuse Sciences Inc. (Jun 18, 1996)
- Manufacturing and Supply Agreement - Pasteur Merieux Serums & Vaccins, DrugAbuse Sciences SA and DrugAbuse Sciences Inc. (Jun 8, 1999)
- Patent and Know-How License Agreement - Pasteur Merieux Serums & Vaccins and DrugAbuse Sciences Inc. (Jun 8, 1999)
- Product License Agreement - Southern Research Institute and Drug Abuse Sciences Inc. (2000)
- Product License Agreement - Southern Research Institute and DrugAbuse Sciences Inc. (Jul 1, 1999)
- Research Agreement With Option to License - Southern Research Institute and DrugAbuse Sciences Inc. (Feb 13, 1997)
- Research Agreement With Option to License - Southern Research Institute and DrugAbuse Sciences Inc. (Jan 21, 2000)
- Supply Agreement - Pharmaceutical Group of Mallinckrodt Inc. and DrugAbuse Sciences Inc. (Jun 9, 2000)
- Supply and Manufacturing Agreement - DrugAbuse Sciences Inc. and Eon Labs Manufacturing Inc. (Jul 20, 2000)
Elan Corp. plc
- Antegren Development and Marketing Collaboration Agreement - Biogen Inc. and Elan Pharma International Ltd. (Aug 15, 2000)
- Asset Purchase Agreement - Elan Corp. plc, Elan Pharma International Ltd., Elan Pharmaceuticals Inc., King Pharmaceuticals Inc., Jones Pharma Inc. and Monarch Pharmaceuticals Inc. (May 19, 2003)
- Asset Purchase Agreement - Elan Corp. plc, Elan Pharmaceuticals Inc., Elan Operations Inc., Elan Canada Inc. and Enzon Inc. (Oct 1, 2002)
- CA-South San Francisco-651 Gateway Boulevard Sublease - Elan Pharmaceuticals Inc. and Tercica Medica Inc. (Jun 24, 2002)
- CA-South San Francisco-651 Gateway Boulevard Sublease - Elan Pharmaceuticals Inc. and Tercica Medica Inc. (Mar 21, 2003)
- Consulting Agreement - Athena Neurosciences Inc. and Dennis J. Selkoe (Jul 1, 1986)
- Consulting Agreement - Dennis J. Selkoe and Elan Pharmaceuticals Inc. (Apr 1, 2002)
- Development, Licence and Supply Agreement [Amendment] - Elan Corp. plc and Ligand Pharmaceuticals Inc. (Aug 20, 1999)
- Distributorship Agreement - Ligand Pharmaceuticals Inc. and Elan Pharma International Ltd. (Feb 28, 2001)
- Incentive Agreement - Monksland Holdings BV, Elan International Services Ltd. and Ligand Pharmaceuticals Inc. (Dec 31, 1999)
- Investors' Rights Agreement - Nanogen Inc., Enterprise Management Partners, Kleiner Perkins Caufield & Byers, InterWest Partners, Sprout Group, DLJ Capital Corp., National Union Fire Insurance Co. of Pittsburgh, PA., Elan International Services Ltd., Integral Capital Partners, MDS Inc., Vulcan Ventures Inc. and Oracle Partners (May 5, 1997)
- License Agreement - Elan Pharmaceutical Technologies and Ligand Pharmaceuticals Inc. (Sep 28, 1998)
- Research and Development Agreement - Nanogen Inc. and Elan Corp. plc (Dec 12, 1997)
Eli Lilly and Co.
Emergent BioSolutions Inc.
- Agreement - Free State of Bavaria and VIVACS GmbH (Jun 16, 2005)
- BT Vaccine Development Agreement - Emergent BioSolutions Inc. and the Health Protection Agency (Nov 23, 2004)
- BioThrax Vaccine Supply Agreement - BioPort Corp. and Centers for Disease Control and Prevention (May 5, 2005)
- Consulting Services Agreement - Emergent BioSolutions Inc. and Hauer Group (Mar 1, 2006)
- Employment Agreement - Emergent BioSolutions Inc. and Fuad El-Hibri (Aug 9, 2006)
- Employment Agreement - Emergent BioSolutions Inc. and Steven Chatfield (Jul 11, 2006)
- Employment Contract - Emergent Europe Ltd. and Steven N. Chatfield (Dec 22, 2005)
- Employment Contract - Emergent Product Development UK Ltd. and Steven N. Chatfield (Sep 21, 2006)
- Exclusive Distribution Agreement - Emergent BIoSolutions Inc. and Health Protection Agency (Nov 23, 2004)
- Filling Services Agreement - BioPort Corp. and Hollister-Stier Laboratories LLC (Mar 18, 2002)
- Licence and Co-Development Agreement - Emergent Europe Ltd. and Sanofi Pasteur SA (May 6, 2006)
- MD-Rockville-2273 Research Boulevard Lease - Brandywine Research LLC and Emergent BioSolutions Inc. (Jun 27, 2006)
- Marketing Agreement - BioPort Corp. and Intergen NV (Jan 1, 2000)
- Product Supply Agreement - Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc. (Jun 12, 2006)
- Services Agreement - East West Resources Corp. and Emergent BioSolutions Inc. (Aug 1, 2006)
- Severance Plan and Termination Protection Program - Emergent BioSolutions Inc.
- UK-Berkshire-Wokingham-Winnersh Triangle-Winnersh 540 Lease - Slough Properties Ltd. and Azur Environmental Ltd. (Dec 13, 1996)
- rBOT Vaccine License Agreement - Emergent BioSolutions Inc. and the Health Protection Agency (Nov 23, 2004)
EntreMed Inc.
- Agreement - Celgene Corp., Children's Medical Center Corp., Bioventure Investments kft and EntreMed Inc. (Aug 2001)
- Agreement - Cytokine Securities Inc. and Innovative Therapeutics Inc. (Jul 2, 1996)
- Analog Agreement - Children's Medical Center Corp. and EntreMed Inc. (Aug 6, 2001)
- Bioprocessing Services Agreement - EntreMed Inc. and Covance Biotechnology Services Inc. (Oct 16, 1998)
- Bioprocessing Services Agreement - EntreMed Inc. and Covance Biotechnology Services Inc. (Jul 7, 1999)
- Change in Control Agreement - EntreMed Inc. and Neil J. Campbell (Aug 1, 2002)
- Collaborative Research and License Agreement [Termination] - Bristol-Myers Squibb Co. and EntreMed Inc. (Aug 5, 1997)
- Confidential Separation Agreement and General Release - EntreMed Inc. and Edward R. Gubish (Sep 18, 2002)
- Employment Agreement - Cytokine Sciences Inc. and Charles Kirkpatrick (Jul 2, 1996)
- Employment Agreement - EntreMed Inc. and John W. Holaday Jr. (Jan 1, 1999)
- Employment Agreement - EntreMed Inc. and Neil J. Campbell (Apr 30, 2003)
- Exclusive License Agreement - Celgene Corp., Children's Medical Center Corp. and EntreMed Inc. (Dec 31, 2002)
- Letter of Intent - EntreMed Inc. and Covance Biotechnology Services Inc. (Aug 30, 1999)
- License Agreement - Children's Medical Center Corp. and EntreMed Inc. (Dec 5, 1996)
- License Agreement - Children's Medical Center Corp. and EntreMed Inc. (Dec 20, 1996)
- License Agreement - EntreMed Inc. and Celgene Corp. (Dec 9, 1998)
- MD-Rockville-9640 Medical Center Drive Lease - Red Gate III LP and EntreMed Inc. (Jun 10, 1998)
- Manufacturing Services Agreement - Chiron Corp. and EntreMed Inc. (Apr 13, 2000)
- Master Consulting Agreement - Interneuron Pharmaceuticals Inc. and Quintiles Inc. (Jul 12, 1996)
- Purchase Agreement - Bioventure Investments kft and EntreMed Inc. (Jun 14, 2001)
- Purchase Agreement [Amendment No. 1] - Bioventure Investments kft and EntreMed Inc. (Jul 13, 2001)
- Purchase Agreement [Amendment No. 2] - Bioventure Investments kft and EntreMed Inc. (Jul 30, 2001)
- Purchase Agreement [Amendment No. 3] - Bioventure Investments kft and EntreMed Inc. (Aug 3, 2001)
- Research Agreement - Children's Hospital and EntreMed Inc. (Oct 1, 1999)
- Research Agreement - EntreMed Inc. and Cytokine Sciences Inc. (Jul 2, 1996)
- Sponsored Research Agreement [Amendment No. 1] - Children's Hospital and EntreMed Inc. (Dec 6, 2000)
- Transition Agreement - EntreMed Inc. and John W. Holaday (Jan 31, 2003)
Enzon Pharmaceuticals Inc.
Eon Labs Inc.
EpiCept Corp.
Exelixis Inc.
F. Hoffman-La Roche Ltd.
- Agreement - F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Oct 20, 1999)
- Agreement - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Oct 20, 1999)
- Agreement [Amendment No. 1] - F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Feb 23, 2001)
- Agreement [Amendment No. 2] - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd., and Protein Design Labs Inc. (Feb 23, 2001)
- Agreement [Amendment] - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Jun 2, 2000)
- Development and License Agreement - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jul 1, 1999)
- Development and License Agreement [Amendment] - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jan 5, 2004)
- Development and License Agreement [Amendment] - Trimeris Inc., F. Hoffmann-La Roche Ltd. and Hoffman-La Roche Inc. (Jul 12, 2004)
- Financing Agreement - Trimeris Inc. and Roche Finance Ltd. (Jul 9, 1999)
- Immunity Agreement - Roche Molecular Systems Inc. and ViroLogic Inc. (Aug 4, 1997)
- License Agreement - F. Hoffman-La Roche & Co. Ltd. and Protein Design Labs Inc. (Jan 31, 1989)
- License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and Human Genome Sciences Inc. (Mar 12, 1996)
- License Agreement - Hoffman-La Roche Inc. and Protein Design Labs Inc. (Jan 31, 1989)
- License and Supply Agreement - CombiMatrix Corp. and Roche Diagnostics GmbH (Jul 1, 2001)
- License and Supply Agreement [Amendment No. 1] - CombiMatrix Corp. and Roche Diagnostics GmbH (Nov 30, 2001)
- Nonexclusive Sublicense Agreement - Seragen Inc., Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd. (Sep 8, 1999)
- Patent License Agreement - F. Hoffman-La Roche Ltd., Roche Molecular Systems Inc. and Invitrogen Corp. (Jul 1, 1998)
- Research & Development Agreement - Roche Diagnostics GmbH and CombiMatrix Corp. (Jun 18, 2001)
- Research Agreement - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jan 1, 2000)
- Research Agreement [Amendment No. 1] - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Nov 13, 2003)
- Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics Inc. (Feb 1, 1998)
- Research Collaboration and Cross-License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and deCODE genetics ehf. (Feb 1, 2002)
- Research Collaboration and License Agreement - Syntex (U.S.A.) Inc. and Tularik Inc. (Jul 8, 1997)
- Research Collaboration and License Agreement [Amendment No. 1] - Tularik Inc. and Syntex (U.S.A.) Inc. (Dec 19, 1997)
- Research Collaboration and License Agreement [Amendment No. 2] - Tularik Inc. and Syntex (U.S.A.) LLC (Aug 31, 2000)
- Settlement and Participation Agreement - Tanox Biosystems Inc. and F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., Roche Holding Ltd. and Roche Holdings Inc. (Jul 8, 1996)
- Stock and Warrant Purchase Agreement - Roche Finance Ltd. and deCODE genetics Inc. (Feb 1, 1998)
- Strategic Marketing Alliance Agreement - Roche Diagnostics Corp., Bio-Reference Laboratories Inc. and CareEvolve.com Inc. (Dec 31, 2001)
- Supply and Distributorship Agreement - ACLARA BioSciences Inc. and Roche Diagnostics Corp. (Oct 26, 2001)
- Termination Agreement - Roche Diagnostics Corp. and ACLARA BioSciences Inc. (Oct 10, 2002)
- Worldwide Agreement - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design labs Inc. (Oct 1, 2003)
Genentech Inc.
- Collaboration Agreement - Genetech Inc. and TolerRx Inc. (Dec 23, 2002)
- Development Collaboration and License Agreement - Genetech Inc. and CytoTherapeutics Inc. (Nov 22, 1996)
- Discontinuation Agreement - Alkermes Inc. and Genentech Inc. (Apr 4, 1999)
- International License and Collaboration Agreement - Genentech Inc. and Tercica Medica Inc. (Jul 25, 2003)
- License Agreement - Alkermes Controlled Therapeutics Inc. and Genentech Inc. (Apr 14, 1999)
- License Agreement - Genentech Inc. and MedImmune Inc. (Jun 4, 1997)
- License and Collaboration Agreement - Genentech Inc. and Tercica Medica Inc. (Apr 15, 2002)
- License and Collaboration Agreement [Amendment No. 1] - Tercica Medica Inc. and Genentech Inc. (Jul 25, 2003)
- License and Supply Agreement - VaxGen Inc. and Genentech Inc. (May 1, 1996)
- Manufacture and Supply Agreement - Genentech Inc. and Alkermes Controlled Therapeutics Inc. (Jan 1, 2000)
- Patent Licensing Master Agreement - Protein Design Labs Inc. and Genentech Inc. (Sep 25, 1998)
- Research Agreement - ACLARA BioSciences Inc. and Genentech Inc. (Jul 17, 2002)
- Research Agreement [Amendment No. 1] - ACLARA BioSciences Inc. and Genentech Inc. (Apr 17, 2003)
- Settlement Agreement - Genentech Inc., Genentech International Ltd., Tanox Biosystems Inc. and Ciba-Geigy Ltd. (Jul 8, 1996)
- Settlement and Cross-License Agreement [Amendment No. 1] - Genentech Inc. and Tanox Inc. (Feb 25, 2004)
- Settlement and Cross-Licensing Agreement - Tanox Biosystems Inc. and Genetech Inc. and Genentech International Ltd. (Jul 8, 1996)
- Tripartite Cooperation Agreement - Novartis Pharma AG, Genentech Inc. and Tanox Inc. (Feb 25, 2004)
GenOdyssee SA
Genzyme Corp.
Geron Corp.
Gilead Sciences Inc.
GlaxoSmithKline
- Asset Purchase Agreement - SmithKline Beecham Clinical Laboratories Inc. and Healtheon Corp. (Dec 31, 1998)
- Asset Sale Agreement - Diversa Corp. and Glaxo Wellcome SA (Jul 18, 2003)
- Assets Purchase Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Dec 31, 1997)
- Collaboration Agreement - Glaxo Research and Development Ltd., Glaxo Group Ltd. and Diversa Corp. (Dec 8, 2000)
- Collaboration Agreement and License Agreement [Amendment] - SmithKline Beecham Corp., SmithKline Beecham plc and Human Genome Sciences Inc. (Jun 28, 1996)
- Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Merck KGaA (Jul 10, 1996)
- Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Synthelabo (Jun 30, 1996)
- Development Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Oct 31, 1997)
- Development and License Agreement - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
- Distribution and Supply Agreement - Smithkline Beecham Corp. d/b/a GlaxoSmithKline and Celgene Corp (Mar 31, 2003)
- Leptin Research, Development and License Agreement - SmithKline Beecham plc and Ligand Pharmaceuticals Inc. (Mar 17, 1998)
- License Agreement - SmithKline Beecham Clinical Laboratories Inc. and ActaMed Corp. (Dec 31, 1997)
- License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc and Human Genome Sciences Inc. (Jun 28, 1996)
- Non-Exclusive License Agreement - ViaCell Inc. and SmithKline Beecham Corp. d/b/a GlaxoSmithKline (Jan 1, 2003)
- Patent License Agreement [IL-5] - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
- Patent Rights Agreement - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
- Registration Rights Agreement - Maxygen Inc. (Nov 13, 2000)
- Research Collaboration and License Agreement - Sequenom Inc., Glaxo Group Ltd. and SmithKline Beecham Corp. (Aug 23, 2001)
- Research Collaboration and License Agreement - SmithKline Beecham plc and MedImmune Inc. (Dec 10, 1997)
- Services Agreement - ActaMed Corp. and SmithKline Beecham Clinical Laboratories Inc. (Dec 31, 1997)
- Services Agreement - Healtheon Corp. and SmithKline Beecham Clinical Laboratories Inc. (Jan 19, 1999)
- Stock Purchase Agreement [Series E Preferred] - Ciphergen Biosystems Inc. (Mar 3, 2000)
- Technology Transfer Agreement - Affymax Technologies NV, Glaxo Group Ltd. and Maxygen Inc. (Feb 1, 1997)
- Therapeutic Collaboration and License Agreement - Human Genome Sciences Inc., Schering Corp., Schering Plough Ltd., SmithKline Beecham Corp. and SmithKline Beecham plc (Jun 28, 1996)
GPC Biotech AG
- 3-Hybrid Collaboration and License Agreement - Altana Pharma AG, Altana Research Institute, GPC Biotech AG and GPC Biotech Inc. (Nov 6, 2003)
- Co-Development and License Agreement - Neotherapeutics Inc. and GPC Biotech AG (Sep 30, 2002)
- Collaboration and License Agreement - BYK Gulden Lomberg Chemische Fabrik GmbH and GPC Biotech AG (Jul 11, 2001)
- Collaboration and License Agreement - GPCAG-Genome Pharmaceuticals Corp. and Morphosys AG (Apr 15, 1999)
- Collaboration and License Agreement [Amendment No. 1] - BYK Gulden Lomberg Chemische Fabrik GmbH and GPC Biotech AG (Jun 30, 2002)
- Collaboration and License Agreement [Amendment No. 1] - GPS Biotech AG and Morphosys AG (Dec 4, 2000)
- Collaboration and License Agreement [Amendment No. 2] - Altana Pharma AG and GPC Biotech AG (Jan 31, 2003)
- Collaboration and License Agreement [Amendment No. 2] - GPC Biotech AG and Morphosys AG (Feb 23, 2004)
- Collaborative Research, Development and Marketing Agreement - Mitotix Inc. and DuPont Merck Pharmaceutical Co. (Jun 2, 1997)
- Collaborative Research, Development and Marketing Agreement [Amendment No. 1] - Mitotix Inc. and DuPont Pharmaceuticals Co. (Apr 3, 2000)
- Collaborative Research, Development and Marketing Agreement [Amendment No. 4] - Mitotix Inc. and Bristol-Myers Squibb Pharma Co. (Dec 28, 2000)
- Service Agreement - GPC Biotech AG and Bernd Robert Seizinger (Jun 1, 2003)
- Service Agreement - GPC Biotech AG and Elmar Maier (Mar 5, 2004)
- Service Agreement - GPC Biotech AG and Mirko Scherer (Sep 1, 2003)
- Service Agreement - GPC Biotech AG and Sebastian Meier-Ewert (Mar 5, 2004)
- Service Agreement [Addendum] - GPC Biotech AG and Bernd Robert Seizinger (May 1, 2003)
- Service Agreement [Addendum] - GPC Biotech AG and Elmar Maier (May 1, 2003)
- Service Agreement [Addendum] - GPC Biotech AG and Mirko Scherer (May 1, 2003)
- Service Agreement [Addendum] - GPC Biotech AG and Sebastian Meier-Ewert (May 1, 2003)
Hoechst AG
- Collaborative Research and Development Agreement - Hoechst Research & Technology Deutschland GmbH & CO. KG and Nanogen Inc. (Dec 3, 1998)
- Collaborative Research and Development Agreement [Offer Letter] - Nanogen Inc. and Hoechst AG (Dec 4, 1997)
- Contribution Agreement - Aventis Research & Technologies GmbH & Co. KG, Nanogen Inc. and Nanogen Recognomics GmbH (Jun 27, 2001)
- Cooperation and Shareholders' Agreement - Aventis Research & Technologies GmbH & Co. KG, Nanogen Inc. and Nanogen Recognomics GmbH (Jun 29, 2001)
- License Agreement - Sepracor Inc. and Hoechst Marion Roussel Inc. (Aug 31, 1999)
- License Agreement - Sepracor Inc. and Hoechst Marion Roussel Inc. (Aug 31, 1999)
- Stock Purchase Agreement - Sepracor Inc. and Marion Merrell Dow Inc. (Jun 1, 1993)
- Warrant To Purchase Common Stock - Nanogen Inc. and Aventis Research and Technologies Verwaltungs GmbH (Sep 22, 2000)
Human Genome Sciences Inc.
- Agency Agreement - Human Genome Sciences Inc. and Wachovia Development Corp. (Jun 30, 2003)
- Assignment of Liquid Collateral Agreement - Human Genome Sciences Inc. and Wachovia Bank NA (Jun 30, 2003)
- Collaboration Agreement and License Agreement [Amendment] - SmithKline Beecham Corp., SmithKline Beecham plc and Human Genome Sciences Inc. (Jun 28, 1996)
- Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Merck KGaA (Jul 10, 1996)
- Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Synthelabo (Jun 30, 1996)
- Construction Agency Agreement - Genome Statutory Trust 2001A and Human Genome Sciences Inc. (Nov 7, 2001)
- Employment Agreement - Human Genome Sciences Inc. and William A. Haseltine (Feb 25, 1997)
- Gene Therapy Collaboration and License - Human Genome Sciences Inc., Schering Corp. and Schering Plough Ltd. (Jun 28, 1996)
- Gene Therapy Collaboration and License Agreement - Human Genome Sciences Inc. and Transgene SA (Feb 25, 1998)
- Lease - Wachovia Development Corp. and Human Genome Sciences Inc. (Jun 30, 2003)
- License Agreement - F. Hoffman-La Roche Ltd., Hoffman-La Roche Inc. and Human Genome Sciences Inc. (Mar 12, 1996)
- License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc and Human Genome Sciences Inc. (Jun 28, 1996)
- MD-Montgomery County Lease - Wells Fargo Bank Northwest NA and Human Genome Sciences Inc. (Oct 25, 2001)
- MD-Montgomery County Lease [Amendment No. 1] - Wells Fargo Bank NA and Human Genome Sciences Inc. (Mar 29, 2002)
- MD-Montgomery County-Johns Hopkins Belward Research Campus Lease - Maryland Economic Development Corp. and Human Genome Sciences Inc. (Dec 1, 1999)
- MD-Rockville Lease - Genome Statutory Trust 2001A and Human Genome Sciences Inc. (Nov 7, 2001)
- MD-Rockville-9800 Medical Center Drive Contract of Sale - Invitrogen Corp. and Human Genome Sciences Inc. (Mar 7, 2001)
- Research Collaboration Agreement - Pioneer Hi-Bred International Inc. and Human Genome Sciences Inc. (Jan 19, 1996)
- Security Agreement - Wachovia Development Corp., Wachovia Bank NA and Human Genome Sciences Inc. (Jun 30, 2003)
- Therapeutic Collaboration and License Agreement - Human Genome Sciences Inc., Schering Corp., Schering Plough Ltd., SmithKline Beecham Corp. and SmithKline Beecham plc (Jun 28, 1996)
ICOS Corp.
Immune Response Corp.
- CA-Carlsbad-5931 Darwin Court Lease - The Childs Family Investment Partnership LP, The A.J. Gardner Family Trust and Immune Response Corp. (Dec 15, 1997)
- Common Stock Purchase Agreement - Immune Response Corp. and Agouron Pharmaceuticals Inc. (Jun 11, 1998)
- Employment Agreement - Immune Response Corp. and John Bonfiglio (Dec 30, 2002)
- Indication of Interest - Immune Response Corp. and Strong River Investments Inc. (Oct 20, 1999)
- Letter of Intent - Agouron Pharmaceuticals Inc. and Immune Response Corp. (Jun 11, 1998)
- PA-King of Prussia-660 Allendale Road - Brandywine Operating Partnership LP and Immune Response Corp. (May 22, 2000)
- PA-King of Prussia-680 Allendale Road Lease - Brandywine Operating Partnership LP and Immune Response Corp. (Nov 1, 1999)
- Preferred Stock Purchase Agreement - MicroGenomics Inc. and Immune Response Corp. (Dec 13, 2000)
- Secured Promissory Note - Immune Response Corp. and Cheshire Associates LLC (Dec 10, 2002)
- Unit Purchase Agreement - Immune Response Corp. and Dennis J. Carlo (Apr 15, 1997)
- Unit Purchase Agreement - Immune Response Corp. and Kevin B. Kimberlin (Apr 15, 1997)
- Warrant Agreement - Immune Response Corp. and Cheshire Associates LLC (Dec 10, 2002)
Incyte Corp.
- 1991 Stock Plan - Incyte Genomics Inc. (Feb 15, 2001)
- 1993 Directors' Stock Option Plan - Incyte Corp. (Jun 23, 2003)
- 1993 Directors' Stock Option Plan - Incyte Genomics Inc. (May 1, 2001)
- 1997 Employee Stock Purchase Plan - Incyte Corp. (Apr 15, 2003)
- Bylaws - Incyte Genomics Inc. (Jun 4, 2002)
- Collaborative Agreements, GEM Services Agreement and Custom Sequencing Services Agreement [Termination] - Incyte Genomics Inc. and Schering-Plough Ltd. (Sep 5, 2002)
- DE-Newark-1090 Elkton Road Lease - E. I. DuPont de Nemours and Co. and Incyte Genomics Inc. (Feb 28, 2002)
- DE-Route 141 and Powder Mill Road Sublease - E. I. Du Pont de Nemours and Co. and Incyte Corp. (Jun 16, 2003)
- Employment Agreement - Incyte Genomics Inc. and E. Lee Bendekgey (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and James P. Merryweather (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and James R. Neal (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and John M. Vuko (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and Michael D. Lack (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and Paul Friedman (Nov 21, 2001)
- Employment Agreement - Incyte Genomics Inc. and Paul Friedman (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and Robert B. Stein (Nov 16, 2001)
- Employment Agreement - Incyte Genomics Inc. and Robert B. Stein (Nov 26, 2001)
- Employment Agreement - Incyte Genomics Inc. and Robert Stein (Feb 12, 2003)
- Employment Agreement - Incyte Genomics Inc. and Roy A. Whitfield (May 2, 2001)
- Employment Agreement [Amendment] - Incyte Genomics Inc. (Jul 24, 2002)
- Employment Agreement [Amendment] - Incyte Genomics Inc. and James P. Merryweather (Apr 1, 2002)
- LifeSeq Collaborative Agreement - Incyte Genomics Inc. and Senomyx Inc. (Dec 29, 2000)
- Promissory Note - Incyte Genomics Inc., Brian Metcalf and Heather Metcalf (Apr 22, 2002)
- Promissory Note - Incyte Genomics Inc., Robert B. Stein and Faye E. Stein. (Jun 21, 2002)
- Settlement Agreement - Incyte Genomics Inc. and Affymetrix Inc. (Dec 21, 2001)
- Severance Agreement - Incyte Genomics Inc. and Michael D. Lack (Jul 25, 2002)
- Technology Access and Collaboration Agreement - Sequenom Inc. and Incyte Genomics Inc. (Sep 29, 2000)
- Technology Access and Collaboration Agreement [Addendum] - Sequenom Inc. and Incyte Genomics Inc.
- Transition Agreement - Incyte Genomics Inc. and Roy A. Whitfield (Nov 26, 2001)
- Transition Agreement [Amendment] - Incyte Genomics Inc. and Roy A. Whitfield (Apr 1, 2002)
Indevus Pharmaceuticals Inc.
Intarcia Therapeutics Inc.
- CA-Alameda-1301 Marina Village Parkway Lease - Alameda Real Estate Investments and BioMedicines Inc. (Dec 1, 1998)
- CA-Alameda-1301 Marina Village Parkway Lease [Amendment No. 1] - Marina Village Office Lease and Alameda Real Estate Investments and BioMedicines Inc. (Jun 1, 1999)
- CA-Emeryville-2000 Powell Street Lease - Spieker Properties LP and BioMedicines Inc. (Feb 21, 2001)
- CA-Emeryville-2000 Powell Street Lease [Amendment No. 1] - Spieker Properties LP and BioMedicines Inc. (Mar 22, 2001)
- CA-Emeryville-2000 Powell Street Lease [Amendment No. 2] - CA-Emeryville Properties LP and BioMedicines Inc. (Sep 26, 2003)
- Consulting Agreement - BioMedicines Inc. and Hana Berger Moran (May 1, 1999)
- Contract Research and Development Agreement - BioMedicines Inc. and Boehringer Ingelheim Pharma KG (Jul 17, 1998)
- Employment Agreement - BioMedicines Inc. and Alice Leung (Feb 20, 2004)
- Employment Agreement - BioMedicines Inc. and Curtis L. Scribner (Nov 23, 1999)
- Employment Agreement - BioMedicines Inc. and Dennis G. Blanchett (Aug 14, 1999)
- Employment Agreement - BioMedicines Inc. and Hana Berger Moran (Sep 3, 1999)
- Employment Agreement - BioMedicines Inc. and James Ahlers (May 14, 1999)
- Employment Agreement - BioMedicines Inc. and Peter J. Langecker (Sep 3, 1999)
- Employment Agreement - BioMedicines Inc. and S. Mark Moran (Aug 14, 1997)
- Employment Agreement - BioMedicines Inc. and S. Mark Moran (Nov 23, 1999)
- Employment Agreement - BioMedicines Inc. and Thomas R. Alessi (Nov 30, 1997)
- Interim Development Agreement - Alza Corp. and BioMedicines Inc. (Nov 8, 2000)
- License Agreement - BioMedicines Inc. and Chiron Corp. (Nov 7, 2002)
- License Agreement - Boehringer Ingelheim International GmbH and BioMedicines Inc. (Jul 17, 1998)
- License Agreement - Endorecherche Inc. and BioMedicines Iinc. (Nov 4, 2002)
- License Agreement - G.D. Searle & Co. and BioMedicines Inc. (Dec 15, 1997)
- License Agreement - Schering AG and BioMedicines Inc. (Feb 1, 1999)
- License Agreement [Amendment No. 1] - Schering AG and BioMedicines Inc. ( 03, 2004)
IntraBiotics Pharmaceuticals Inc.
Invitrogen Corp.
- Agreement and Plan of Merger - Invitrogen Corp. and BioReliance Corp. (Dec 24, 2003)
- Asset Purchase Agreement - Genicon Sciences Corp. and Invitrogen Corp. (Jun 27, 2003)
- Asset Purchase Agreement - Invitrogen Corp. and Ciphergen Biosystems Inc. (Jun 25, 2001)
- Board Compensation Agreement - Invitrogen Corp. and Raymond Dittamore (Nov 5, 2001)
- CA-Carlsbad-5781 Van Allen Way Lease - CalWest Industrial Properties LLC and Invitrogen Corp. (May 31, 2001)
- CA-San Diego-1610 Faraday Avenue Lease - Blackmore Lot 99 Investment and Invitrogen Corp. (Dec 20, 1999)
- CA-San Diego-1620 Faraday Avenue Lease - Blackmore Signal Hill and Invitrogen Corp. (Oct 7, 1999)
- Change-In-Control Agreement - Invitrogen Corp. And C. Eric Wizner (May 31, 2002)
- Change-In-Control Agreement - Invitrogen Corp. and Daryl J. Faulkner (May 31, 2002)
- Change-In-Control Agreement - Invitrogen Corp. and John A. Cottingham (Jun 7, 2002)
- Confidential Separation Agreement and General Release of All Claims - Invitrogen Corp. and Lyle C. Turner (Dec 13, 2002)
- Employment Agreement - Invitrogen Corp. and Daryl Faulkner (May 31, 2002)
- Employment Agreement - Invitrogen Corp. and Gregory T. Lucier (May 26, 2003)
- Employment Agreement - Invitrogen Corp. and Lewis J. Shuster (Feb 15, 2000)
- Employment Agreement - Invitrogen Corp. and Theodore De Frank (Sep 28, 1995)
- Employment Agreement - Novel Experimental Technology and David E. McCarty (Jul 22, 1997)
- Executive Employment and Severance Agreement - Invitrogen Corp. and James R. Glynn (Dec 5, 2002)
- Indemnification Agreement - Invitrogen Corp. and Thomas H. Adams (Sep 14, 2000)
- Independent Contractor Services Agreement - Invitrogen Corp. and Lyle C. Turner (Dec 13, 2002)
- License Agreement - Invitrogen Corp. and Diversa Corp. (Mar 29, 1999)
- License Agreement - Molecular Chimerics Corp and Invitrogen Corp. (May 10, 1990)
- License Agreement - Sloan-Kettering Institute for Cancer Research and Invitrogen Corp. (Jan 22, 1997)
- MD-Rockville-9800 Medical Center Drive Contract of Sale - Invitrogen Corp. and Human Genome Sciences Inc. (Mar 7, 2001)
- Patent License Agreement - F. Hoffman-La Roche Ltd., Roche Molecular Systems Inc. and Invitrogen Corp. (Jul 1, 1998)
- Promissory Note - Invitrogen Corp. and Lyle C. Turner (Dec 8, 1998)
- Promotion and Relocation Agreement - Invitrogen Corp. and C. Eriz Wizner (May 31, 2002)
- Protocol Guide - Invitrogen Corp.
- Purchase Agreement - CAYLA and Invitrogen Corp. (Jul 1, 1994)
- Service Agreement - Invitrogen Corp. and Anthony Francis Martin (2000)
- Settlement Agreement - Invitrogen Corp. and Daryl Faulkner (Sep 9, 2002)
- Settlement and Retention Agreement - Invitrogen Corp. and C. Eric Winzer (May 31, 2002)
- Settlement and Retention Agreement - Invitrogen Corp. and Daryl Faulkner (May 31, 2002)
- Settlement and Retention Agreement - Invitrogen Corp. and John A. Cottingham (Jun 7, 2002)
- Stock Purchase Agreement - MorphaGen Inc. and Invitrogen Corp. (Nov 3, 1998)
Johnson & Johnson
King Pharmaceuticals Inc.
Large Scale Biology Corp.
- Business Loan Agreement - SierraWest Bank and Biosource Technologies Inc. (Nov 30, 1998)
- CA-Vacaville-3333 Vaca Valley Parkway Office Lease - Sepulveda Properties Inc. and Biosource (Oct 15, 1997)
- Collaboration and License Agreement - Dow Chemical Co., Dow Agrosciences LLC and Biosource Technologies Inc. (Sep 1, 1998)
- Consultancy Agreement - Large Scale Biology Corp. and N. Leigh Anderson (Jun 4, 2002)
- Consultancy Agreement - Large Scale Biology Corp. and Norman G. Anderson (Jun 4, 2002)
- Consulting Agreement - Large Scale Biology Corp. and William M. Pfann (Nov 12, 2001)
- Employment Agreement - Large Scale Biology Corp. and John D. Fowler Jr. (Jan 29, 2002)
- Employment Agreement - Large Scale Biology Corp. and Ron Artale (Oct 31, 2001)
- Employment Agreement - Large Scale Biology Corp., Biosource Technologies Inc. and N. Leigh Anderson (Jan 25, 1999)
- Employment Agreement - Large Scale Biology Corp., Biosource Technologies Inc. and Norman G. Anderson (Jan 25, 1999)
- Exception Letter - Large Scale Biology Corp. and David R. McGee (Jun 17, 2003)
- Exception Letter - Large Scale Biology Corp. and Robert L. Erwin (Jun 17, 2003)
- MD-Germantown-Goldenrod Lane-Senaca Meadows Corporate Center Lease - Westphalia Center II LP and Large Scale Proteomics Corp. (Jul 18, 2000)
- Notice of Grant Award - National Cancer Institute and Large Scale Biology Corp. (Jan 5, 2000)
- Severance Agreement - Large Scale Biology Corp. and N. Leigh Anderson (Jun 4, 2002)
- Severance Agreement - Large Scale Biology Corp. and Norman G. Anderson (Jun 4, 2002)
Life Sciences Inc.
- Facilities Operation Agreement - LIfe Sciences Inc. and Organon Teknika BV (May 25, 2000)
- Investment Representations and Agreements - Life Sciences Inc. and Louis D. Srybnik (Apr 9, 1999)
- Joint Venture Side Letter - Life Sciences Inc. and Beijing Aokai Automation System Engineering Co. (Jul 18, 2000)
- Letter of Intent - Life Sciences Inc. and 1144668 Ontario Ltd. (Jun 15, 1999)
- Letter of Intent - Life Sciences Inc., Accident Prevention Plus Inc. and Life Sciences Corp. (Feb 9, 2000)
- Letter of Intent - Life Sciences Inc., Beijing Aokai Automation System Engineering Co. and Yamed Medical Instrumentation Co Ltd. (Jul 18, 2000)
- Letter of Understanding - Life Sciences Inc. and Centers for Disease Control (Nov 21, 1999)
- License Agreement - Life Sciences Inc. and Organon Teknika BV (May 25, 2000)
- License Agreement - Organon Teknika BV and Life Sciences Inc. (Jul 9, 1998)
- License Agreement - Organon Teknika BV and Life Sciences Inc. (Mar 31, 1999)
- License Agreement [Addendum] - Organon Teknika BV and Life Sciences Inc. (Sep 28, 1999)
- Sublicense Agreement - Innovative Biotechnologies International Inc. and LIfe Sciences Inc. (Jul 29, 1999)
- Supply Agreement - LIfe Sciences Inc. and Organon Teknika BV (May 25, 2000)
Ligand Pharmaceuticals Inc.
- Asset Purchase Agreement - CoPharma Inc. and Marathon Biopharmaceuticals Inc. and Seragen Inc. (Jan 7, 2000)
- Co-Promotion Agreement - Ligand Pharmaceuticals Inc. and Organon Pharmaceuticals USA Inc. (Jan 1, 2003)
- Commercial Supply Agreement and Process Validation Agreement - Seragen inc. and Hollister-Stier Laboratories LLC (Feb 27, 2004)
- Development, Licence and Supply Agreement [Amendment] - Elan Corp. plc and Ligand Pharmaceuticals Inc. (Aug 20, 1999)
- Distributorship Agreement - Ligand Pharmaceuticals Inc. and Elan Pharma International Ltd. (Feb 28, 2001)
- Distributorship Agreement - Ligand Pharmaceuticals Inc. and Ferrer Internacional SA (Mar 26, 1999)
- Employment Agreement - Ligand Pharmaceuticals Inc. and David E. Robinson (May 1, 1996)
- Employment Agreement - Ligand Pharmaceuticals Inc. and Russell L. Allen (Feb 6, 1997)
- Employment Agreement - Ligand Pharmaceuticals Inc. and William Pettit (Nov 4, 1996)
- Incentive Agreement - Monksland Holdings BV, Elan International Services Ltd. and Ligand Pharmaceuticals Inc. (Dec 31, 1999)
- Leptin Research, Development and License Agreement - SmithKline Beecham plc and Ligand Pharmaceuticals Inc. (Mar 17, 1998)
- Licence and Supply Agreement - Elan Corp. plc and Elan Management Ltd. and Ligand Pharmaceuticals Inc. (Dec 6, 2002)
- License Agreement - Elan Pharmaceutical Technologies and Ligand Pharmaceuticals Inc. (Sep 28, 1998)
- License Agreement - Ligand Pharmaceuticals Inc. and X-Ceptor Therapeutics Inc. (Jun 30, 1999)
- License Agreement - Salk Institute for Biological Studies and Ligand Pharmaceuticals Inc. (Apr 12, 2002)
- Manufacture and Supply Agreement - Seragen Inc. and Cambrex Bio Science Hopkinton Inc. (Jan 1, 2004)
- Manufacturing and Packaging Agreement - Cardinal Health PTS LLC and Ligand Pharmaceuticals Inc. (Feb 13, 2004)
- Master Lease Agreement - USL Capital Corp. and Ligand Pharmaceuticals Inc. (May 30, 1996)
- Nonexclusive Sublicense Agreement - Seragen Inc., Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd. (Sep 8, 1999)
- Option and Wholesale Purchase Agreement - Eli Lilly and Co. and Ligand Pharmaceuticals Inc. (Nov 25, 1997)
- Purchase Agreement - Pharmaceutical Royalties International (Cayman) Ltd. and Ligand Pharmaceuticals Inc. (Mar 6, 2002)
- Purchase Agreement - Pharmaceutical Royalties International (Cayman) Ltd. and Ligand Pharmaceuticals Inc. (Dec 30, 2002)
- Purchase Agreement [Amendment] - Royalty Pharma Finance Trust and Ligand Pharmaceuticals Inc. (Oct 1, 2003)
- Research, Development and License Agreement - Bristol-Myers Squibb Co. and Ligand Pharmaceuticals Inc. (May 19, 2000)
- Research, Development and License Agreement - Organon Co. and Ligand Pharmaceuticals Inc. (Feb 11, 2000)
- Research, Development and License Agreement - Warner-Lambert Co. and Ligand Pharmaceuticals Inc. (Sep 1, 1999)
- Research, Development and License Agreement [Amendment No. 2] - American Home Products Corp. and Ligand Pharmaceuticals Inc. (May 24, 1996)
- Research, Development and License Agreement [Amendment No. 4] - American Home Products Corp. and Ligand Pharmaceuticals Inc. (Sep 9, 1999)
- Royalty Stream Purchase Agreement - Pharmaceutical Partners LLC, Bioventure Investments Kft, Pharmaceutical Royalties LLC, Seragen Inc. and Ligand Pharmaceuticals Inc. (Dec 31, 1999)
- SARM Research, Development and License Agreement - TAP Pharmaceutical Products Inc. and Ligand Pharmaceuticals Inc. (Jun 22, 2001)
- Separation Agreement and General Release - Ligand Pharmaceuticals Inc. and Thomas H. Silberg (Jul 7, 2003)
- Settlement Agreement and Mutual General Release - La Jolla Cancer Research Foundation, SelectRA Pharmaceuticals Inc. and SRI International, Ligand Pharmaceuticals Inc., Allergan Ligand and Allergan Ligand Retinoid Therapeutics Inc. (Aug 23, 1995)
- Settlement Agreement and Mutual Release of All Claims - Ligand Pharmaceuticals Inc. and Pfizer inc. (Apr 22, 1996)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Eric S. Groves (Aug 23, 1999)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Giambattista Aliprandi (May 17, 2001)
- Severance Agreement - Ligand Pharmaceuticals Inc. and James J. L'Italien (Jun 26, 2002)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Martin Meglasson (Feb 26, 2004)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Paul V. Maier (Jul 1, 2003)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Philip A. Duffy (Dec 9, 1999)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Ronald C. Eld (Jul 1, 2003)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Steven D. Reich (Jan 5, 1998)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Thomas H. Silberg (Jan 17, 2000)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Tod G. Mertes (May 20, 2003)
- Severance Agreement - Ligand Pharmaceuticals Inc. and Warner R. Broaddus (Dec 13, 2001)
- Severance Agreement - Ligand Pharmaceuticals Inc. and William A. Pettit (Jul 1, 2003)
- Stock Purchase Agreement - Ligand Pharmaceuticals Inc. (Jan 5, 2001)
- Supply and Development Agreement - Ligand Pharmaceuticals Inc., Seragen Inc. and CoPharma Inc. (Jan 7, 2000)
Lipid Sciences Inc.
- Confidential Separation Agreement and General Release - Lipid Sciences Inc. and Barry D. Michaels (Jan 28, 2003)
- Confidential Separation Agreement and General Release - Lipid Sciences Inc. and Jan Johansson (Jan 28, 2003)
- Employment Agreement - Lipid Sciences Inc. and Barry Michaels (Apr 2, 2001)
- Employment Agreement - Lipid Sciences Inc. and Dale Richardson (Jul 1, 2003)
- Employment Agreement - Lipid Sciences Inc. and Hana Berger Moran (Mar 4, 2002)
- Employment Agreement - Lipid Sciences Inc. and Marc Bellotti (Jul 1, 2003)
- Employment Agreement - Lipid Sciences Inc. and Randy Stolworthy (Nov 30, 2001)
- Employment Agreement - Lipid Sciences Inc. and S. Lewis Meyer (Apr 14, 2003)
- Employment Agreement - Lipid Sciences Inc. and Sandra Gardiner (Feb 1, 2001)
- Service Agreement - Lipid Sciences Inc., Karuba International Pty Ltd. and Bill E. Cham (Nov 27, 2001)
- Service Agreement - Lipid Sciences inc. and H. Bryan Brewer Jr.
- Severance Agreement - Lipid Sciences Inc. and Phillip C. Radlick (Oct 15, 2002)
LumiCyte Inc.
Lumigen Inc.
Mallinckrodt Inc.
MannKind Corp.
- Change of Control Agreement - MannKind Corp. and Dan Burns (Aug 1, 2003)
- Change of Control Agreement - MannKind Corp. and David Thomson (Aug 1, 2003)
- Change of Control Agreement - MannKind Corp. and Dick Anderson (Aug 1, 2003)
- Change of Control Agreement - MannKind Corp. and Hakan Edstrom (Aug 1, 2003)
- Change of Control Agreement - MannKind Corp. and Wendell Cheatham (Aug 1, 2003)
- Executive Severance Agreement - MannKind Corp. and Dan Burns (Aug 1, 2003)
- Executive Severance Agreement - MannKind Corp. and David Thomson (Aug 1, 2003)
- Executive Severance Agreement - MannKind Corp. and Dick Anderson (Aug 1, 2003)
- Executive Severance Agreement - MannKind Corp. and Hakan Edstrom (Aug 1, 2003)
- Executive Severance Agreement - MannKind Corp. and Wendell Cheatham (Aug 1, 2003)
- Supply Agreement - Diosynth BV and Pharmaceutical Discovery Corp. (Jan 1, 2000)
Maxygen Inc.
- Agreement - Maxygen Inc. and Gist-Brocades BV (Mar 15, 1999)
- CA-Redwood City-200 Saginaw Drive Lease - Metropolitan Life Insurance Co. and Maxygen Inc. (Apr 21, 2000)
- CA-Redwood City-200/220 Penobscot Drive Lease [Amendment No. 3] - Metropolitan Life Insurance Co. and Maxygen Inc. (Oct 22, 2003)
- CA-Redwood City-200/220 Penobscot Drive and 501 Chesapeake Drive Lease - Metropolitan Life Insurance Co. and Codexis Inc. (Oct 2003)
- CA-Redwood City-501 Chesapeake Drive Sublease - Cygnus Inc. and Maxygen Inc. (Mar 30, 2001)
- CA-Redwood City-515 Galveston Drive Lease [Amendment No. 1] - Metropolitan Life Insurance Co. and Maxygen Inc. (Feb 26, 1999)
- CA-Redwood City-515 Galveston Drive Lease [Amendment No. 2] - Metropolitan Life Insurance Co. and Maxygen Inc. (Oct 24, 2000)
- Change of Control Agreement - Maxygen Inc.
- Change of Control Agreement - Verdia Inc. and John Bedbrook (Feb 24, 2003)
- Collaboration Agreement - Maxygen Inc. and Zeneca Ltd. (Jun 18, 1999)
- Collaborative Research and Development Agreement - Technological Resources Pty Ltd. and Maxygen Inc. (Jan 19, 2000)
- Collaborative Research and License Agreement - Pioneer Hi-Bred International Inc. and Maxygen Inc. (Dec 23, 1998)
- Cooperative Research and Development Agreement - National Cancer Institute and Maxygen Inc. (Feb 24, 2000)
- DK-Horsholm-1 Agern Alle Lease - Science Park in Horsholm and ProFound Pharma A/S (May 5, 2000)
- Exclusive Consulting Agreement - Maxygen Inc. and Joseph A. Affholter (Jan 28, 2000)
- License and Collaboration Agreement - Maxygen Inc. and Novo Nordisk A/S (Apr 19, 1999)
- Pledge Agreement - Maxygen Inc., Joseph Affholter and Roxanne Affholter (Jan 28, 2000)
- Promissory Note - Maxygen Inc. and John Curd (May 7, 2001)
- Promissory Note - Maxygen Inc., Joseph Affholter and Roxanne Affholter (Apr 22, 1999)
- Promissory Note - Maxygen Inc., Joseph Affholter and Roxanne Affholter (Jan 28, 2000)
- Registration Rights Agreement - Maxygen Inc. (Nov 13, 2000)
- Severance Agreement - Maxygen Inc. and Joseph A. Affholter (Jan 28, 2000)
- Technology Transfer Agreement - Affymax Technologies NV, Glaxo Group Ltd. and Maxygen Inc. (Feb 1, 1997)
Medarex Inc.
MediciNova Inc.
Medicis Pharmaceutial Corp.
MedImmune Inc.
- Asset Purchase Agreement - MedImmune Oncology inc. and MGI Pharma Inc. (Oct 26, 2000)
- Biological Materials License Agreement - Public Health Service and MedImmune inc. (Aug 24, 1994)
- Co-Promotion Agreement - Abbott Laboratories and MedImmune Inc. (Nov 26, 1997)
- Co-Promotion Agreement [Amendment No. 1] - Abbott Laboratories and MedImmune Inc. (Jul 31, 2000)
- Co-Promotion Agreement [Amendment No. 2] - Abbott Laboratories and MedImmune Inc. (Nov 29, 2001)
- Collaboration and License Agreement - Cerus Corp. and MedImmune Inc. (Apr 20, 2004)
- Contract Research and Development Agreement - MedImmune Inc. and Dr. Karl Thomae GmbH (Nov 27, 1997)
- Distribution Agreement - MedImmune Inc. and Abbott International Ltd. (Nov 26, 1997)
- Distribution Agreement [Amendment No. 1] - MedImmune Inc. and Abbott International Ltd. (Apr 28, 1999)
- Distribution Agreement [Amendment No. 2] - MedImmune Inc. and Abbott International Ltd. (Oct 8, 1999)
- Distribution Agreement [Amendment No. 3] - MedImmune Inc. and Abbott International Ltd. (Jul 1, 2003)
- Employment Agreement - MedImmunie Inc. and Harry Greenberg (Mar 26, 2002)
- Employment Agreement - MedImmune Inc. and Armando Anido (Aug 30, 1999)
- Employment Agreement - MedImmune Inc. and Armando Anido (Aug 15, 2002)
- Employment Agreement - MedImmune Inc. and Bogdan Dziurzynski (Apr 1, 1997)
- Employment Agreement - MedImmune Inc. and David M. Mott (Apr 1, 1997)
- Employment Agreement - MedImmune Inc. and David M. Mott (Nov 1, 1998)
- Employment Agreement - MedImmune Inc. and David M. Mott (Aug 15, 2002)
- Employment Agreement - MedImmune Inc. and David P. Wright (Apr 1, 1997)
- Employment Agreement - MedImmune Inc. and David P. Wright (Nov 1, 1998)
- Employment Agreement - MedImmune Inc. and Edward Arcuri (Feb 25, 2002)
- Employment Agreement - MedImmune Inc. and Edward M. Connor (Feb 15, 2001)
- Employment Agreement - MedImmune Inc. and Edward M. Connor (Aug 15, 2002)
- Employment Agreement - MedImmune Inc. and Franklin H. Top Jr. (Apr 1, 1997)
- Employment Agreement - MedImmune Inc. and Franklin H. Top Jr. (Nov 1, 1998)
- Employment Agreement - MedImmune Inc. and Gail Folena-Wasserman (Apr 18, 2001)
- Employment Agreement - MedImmune Inc. and Gail M. Folena-Wasserman (Aug 15, 2002)
- Employment Agreement - MedImmune Inc. and Gregory S. Patrick (Feb 15, 2001)
- Employment Agreement - MedImmune Inc. and James F. Young (Apr 1, 1997)
- Employment Agreement - MedImmune Inc. and James F. Young (Nov 1, 1998)
- Employment Agreement - MedImmune Inc. and James F. Young (Nov 1, 2000)
- Employment Agreement - MedImmune Inc. and James F. Young (Aug 15, 2002)
- Employment Agreement - MedImmune Inc. and Melvin D. Booth (Nov 1, 1998)
- Employment Agreement - MedImmune Inc. and Wayne T. Hockmeyer (Apr 11, 1997)
- Employment Agreement - MedImmune Inc. and Wayne T. Hockmeyer (Nov 1, 1998)
- Employment Agreement - MedImmune Inc. and Wayne T. Hockmeyer (May 31, 2000)
- Employment Agreement - MedImmune inc. and Bogdan Dziurzynski (Nov 1, 1998)
- Employment Agreement - MedImmune inc. and Melvin D. Booth (Aug 15, 2002)
- Engineering, Procurement, Construction and Validation Services Agreement - MedImmune Inc. and Fluor Daniel Inc. (Aug 9, 1996)
- FluMist(R) Supply Agreement [Amendment No. 2] - MedImmune Vaccines Inc. and Wyeth (Oct 23, 2002)
- General Conditions of the Contract for Construction [Supplement] - MedImmune Inc. and HITT Contracting Inc. (Aug 7, 2002)
- Letter Agreemenet re: Supply of Frozen Product for 2002-03 Flu Season - MedImmune Vaccines Inc. and Wyeth (Oct 23, 2002)
- License Agreement - Genentech Inc. and MedImmune Inc. (Jun 4, 1997)
- License Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- License Agreement - Loyola University of Chicago and MedImmune Inc. (Dec 3, 1997)
- License Agreement - Medical Research Council and MedImmune Inc. (Aug 13, 1997)
- License Agreement - University of Iowa Research Foundation and MedImmune Inc. (Dec 12, 1997)
- License and Research Support Agreement - MedImmune Inc. and Rockefeller University (Apr 16, 1996)
- MD-Gaithersburg-35 West Watkins Mill Road Lease [Amendment No. 1] - Clopper Road Associates and MedImmune Inc. (Jun 8, 1993)
- MD-Gaithersburg-35 West Watkins Mill Road Lease [Amendment No. 2] - Clopper Road Associates and MedImmune Inc. (Jun 30, 1993)
- MD-Gaithersburg-35 West Watkins Mill Road Lease [Amendment No. 3] - Clopper Road Associates and MedImmune Inc. (Apr 15, 1996)
- MD-Gaithersburg-35 West Watkins Mill Road Lease [Amendment No. 4] - Clopper Road Associates and MedImmune Inc. (Oct 3, 1996)
- MD-Gaithersburg-35 West Watkins Mill Road Lease [Amendment No. 5] - Clopper Road Associates and MedImmune Inc. (Oct 3, 1996)
- MD-Gaithersburg-35 West Watkins Mill Road Lease [Amendment No. 6] - ARE-QRS Corp. and MedImmune Inc. (Sep 10, 1997)
- MD-Gaithersburg-55 West Watkins Mill Road Lease - MOR Bennington LLLP and MedImmune Inc. (Oct 8, 1999)
- Manufacturing Agreement - MedImmune Inc. and Dr. Karl Thomae GmbH (Nov 27, 1997)
- Master Amendment Agreement - MedImmune Vaccines Inc. and Wyeth (Sep 30, 2002)
- Master Loan and Security Agreement - MedImmune Inc. and Transamerica Business Credit Corp. (Jun 16, 1997)
- Patent License Agreement [CD-2] - Protein Design Labs Inc. and MedImmune Inc. (Jul 17, 1997)
- Patent License Agreement [RSV] - Protein Design Labs Inc. and MedImmune Inc. (Jul 17, 1997)
- Plasma Supply Agreement - DCI Management Group Inc. and MedImmune Inc. (Feb 6, 1996)
- RSVIG Termination Agreement - MedImmune Iinc. and Wyeth-Ayerst Pharmaceuticals Inc. (Dec 17, 1999)
- Research Collaboration and License Agreement - SmithKline Beecham plc and MedImmune Inc. (Dec 10, 1997)
- Research and Assignment and License Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- Research and License Agreement - OraVax Merieux Co., Merieux OraVax SNC, and MedImmune Inc. (Nov 1, 1996)
- Selection Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- Selection Agreement [Amendment] - MedImmune Inc. and Applied Molecular Evolution Inc. (Mar 8, 2001)
- Settlement Agreement and RSV License Agreement [Amendment] - MedImmune Inc. and Massachusetts Biologic Laboratories (Dec 16, 2002)
- Stipulated Sum Agreement - MedImmune Inc. and HITT Contracting Inc. (Jun 28, 2002)
- Stock Purchase Agreement - Ixsys Inc. and MedImmune Inc. (Feb 24, 1999)
- Sublicense Agreement - Centocor Inc. and MedImmune Inc. (Sep 15, 2000)
- United States License and Co-Promotion Agreement [Amendment No. 1] - MedImmune Vaccines Inc. and Wyeth (Oct 23, 2002)
Merck & Co. Inc.
- 2001 Incentive Stock Plan - Merck & Co. Inc. (Jul 22, 2003)
- 2004 Incentive Stock Plan [Amendment] - Merck & Co. Inc. (Nov 23, 2004)
- Change in Control Separation Benefits Plan - Merck & Co. Inc. (Nov 23, 2004)
- Collaboration and License Agreement - SmithKline Beecham Corp., SmithKline Beecham plc, Human Genome Sciences Inc. and Merck KGaA (Jul 10, 1996)
- Collaboration and License Agreement - Tularik Inc. and Merck & Co. Inc. (Dec 22, 1996)
- Collaborative Research and License Agreement [Amendment No. 1] - Merck & Co. Inc. and Cubist Pharmaceuticals Inc. (Oct 30, 1997)
- Collaborative Research and License Agreement [Amendment No. 2] - Merck & Co. Inc. and Cubist Pharmaceuticals Inc. (Apr 30, 1998)
- Collaborative Research, Development and Marketing Agreement - Mitotix Inc. and DuPont Merck Pharmaceutical Co. (Jun 2, 1997)
- Employment Agreement - Medco Containment Services Inc. and Per G.H. Lofberg (Jul 27, 1993)
- Employment Agreement - Merck & Co. Inc. and Edward M. Scolnick (Jan 3, 2003)
- Employment Agreement - Merck & Co. Inc. and Peter S. Kim (Dec 15, 2000)
- Employment Agreement - Merck-Medco Managed Care Inc. and Per G.H. Lofberg (May 25, 1996)
- Employment Agreement - Merck-Medco Managed Care LLC and Per G.H. Lofberg (Nov 27, 2000)
- KBI Shares Option Agreement - Astra AB, Merck & Co. Inc. and Merck Holdings Inc. (Jul 1, 1998)
- KBI Supply Agreement - Astra Merck Inc. and Astra Pharmaceuticals LP (Jul 1, 1998)
- KBI-E Asset Option Agreement - Astra AB, Merck & Co. Inc., Astra Merck Inc. and Astra Merck Enterprises Inc. (Jul 1, 1998)
- License and Option Agreement - Astra AB and Astra Merck Inc. (Jul 12, 1982)
- Manufacturing Agreement - Merck & Co. Inc., Astra AB, Astra Merck Inc. and Astra USA Inc. (Jul 1, 1998)
- Master Restructuring Agreement - Astra AB, Merck & Co. Inc., Astra Merck Inc., Astra USA Inc., KB USA LP, Astra Merck Enterprises Inc., KBI Sub Inc., Merck Holdings Inc. and Astra Pharmaceuticals LP (Jun 19, 1998)
- Non-Qualified Stock Option Agreement - Medco Containment Services Inc. and Per G.H. Lofberg (Jul 1, 1991)
- Research Collaboration and License Agreement - deCODE genetics Inc., deCODE genetics ehf. and Merck & Co. Inc. (Sep 26, 2002)
- Stock Purchase Agreement - Merck & Co. Inc. and Raymond V. Gilmartin (Jun 16, 1999)
MGI PHARMA Inc.
Molecular Analytical Systems Inc.
- Assignment Agreement - Ciphergen Biosystems Inc., IllumeSys Pacific Inc., Ciphergen Technologis Inc., Molecular Analytical Systems Inc., LumiCyte Inc. and T. William Hutchens (May 28, 2003)
- Exclusive License Agreement - Molecular Analytical Systems Inc. and Ciphergen Biosystems Inc. (Feb 21, 2003)
- Settlement Agreement and Mutual General Release - Ciphergen Biosystems Inc., IllumeSys Pacific Inc., Ciphergen Technologies Inc., Molecular Analytical Systems Inc., LumiCyte Inc. and T. William Hutchens (May 28, 2003)
- Technology Transfer Agreement - Molecular Analytical Systems Inc. and ISP Acquisition Corp. (Apr 7, 1997)
- Technology Transfer Agreement - Molecular Analytical Systems Inc. and Illumesys Pacific Inc. (Apr 7, 1997)
- Technology Transfer Agreement - Molecular Analytical Systems Inc. and Lumigen Corp. (Sep 1, 1999)
- Technology Transfer Agreement II - Molecular Analytical Systems Inc. and LumiCyte Inc. (Feb 29, 2000)
- Technology Transfer Agreement II [Amendment No. 1] - Molecular Analytical Systems Inc. and LumiCyte Inc. (Nov 6, 2001)
- Transfer Agreement [Amendment No. 1] - Molecular Analytical Systems Inc. and Lumigen Corp. (Nov 6, 2001)
Natrol Inc.
- CA-Chatsworth-21411 Prairie Street Lease [Amendment No. 1] - Lincoln-Whitehall Pacific LLC and Natrol Inc. (Nov 22, 1996)
- CA-Chatsworth-21411 Prairie Street Purchase and Sale Agreement - WHLW Real Estate LP, Natrol Real Estate Inc. and Natrol Inc. (Dec 22, 1998)
- CA-Chatsworth-9453 Owensmouth Avenue Purchase and Sale Agreement - WHLW Real Estate LP and Natrol Real Estate II Inc. (Nov 22, 1999)
- Distributorship/Packager/Supply Agreement - Inter-Cal Corp. and Natrol Inc. (Jan 1, 1995)
- Employment Agreement - Natrol Inc. and John Denis (Jul 18, 1997)
- Incentive Stock Option Agreement - Natrol Inc. and Laura Moore (Apr 8, 1998)
- Indemnification Agreement - Natrol Inc. and Elliott Balbert (Sep 30, 1996)
- Pledge Agreement - Natrol Inc. and Dennis Jolicoeur (Nov 14, 1996)
- Promissory Note - Natrol Inc. and Dennis R. Jolicoeur (Nov 14, 1996)
- Restricted Stock Agreement - Natrol Inc. and Dennis Jolicoeur (Nov 14, 1996)
- Supply Agreement - Basic Vegetable Products LP and Natrol Inc. (Feb 27, 1998)
- Supply Agreement and Royalty Agreement [Amendment No. 1] - Basic Vegetable Products LP, Natrol Inc. and ConAgra Foods Inc. (Nov 7, 2000)
Novartis
- Ancillary Development & Licensing Agreement - Novartis Pharma AG and Tanox Inc. (Feb 25, 2004)
- Collaboration Agreement - Novartis Agribusiness Biotechnology Research Inc. and Diversa Corp. (Jan 25, 1999)
- Collaboration Agreement - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (May 26, 1999)
- Collaboration Agreement [Amendment No. 1] - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (May 18, 2001)
- Collaboration Agreement [Amendment No. 2] - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (Jul 6, 2001)
- Collaborative Research and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 4, 2002)
- Collaborative Research and License Agreement - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 3, 1999)
- Collaborative Research and License Agreement - Novartis Pharma AG and Celgene Corp. (Dec 20, 2000)
- Development and License Agreement - Celgene Corp. and Novartis Pharma AG (Apr 19, 2000)
- Development and Licensing Agreement - Tanox Inc. and Novartis Pharma AG (Feb 25, 2004)
- Joint Venture Agreement - Diversa Corp. and Novartis Seeds AG (Dec 1, 1999)
- Research and Development Agreement - Novartis Enzymes Inc. and Diversa Corp. (Dec 1, 1999)
- Stock Purchase Agreement - Diversa Corp. and Novartis Agribusiness Biotechnology Research Inc. (Jan 25, 1999)
- Stock Purchase Agreement - Novartis Pharma AG and Cubist Pharmaceuticals Inc. (Feb 1999)
- Tripartite Cooperation Agreement - Novartis Pharma AG, Genentech Inc. and Tanox Inc. (Feb 25, 2004)
Novavax Inc.
- Co-Promotion Agreement [Amendment No. 1] - King Pharaceuticals Inc. and Novavax Inc. (Jun 29, 2001)
- Co-Promotion Agreement [Amendment No. 2] - King Pharmaceuticals Inc. and Novavax Inc. (Jun 29, 2001)
- Employment Agreement - Novavax Inc. and Ann Oliver McGeehan (Jan 14, 2002)
- Employment Agreement - Novavax Inc. and Brenda Fugagli (Jul 24, 1998)
- Employment Agreement - Novavax Inc. and D. Craig Wright (Mar 31, 1998)
- Employment Agreement - Novavax Inc. and Dennis Genge (Jan 1, 2002)
- Employment Agreement - Novavax Inc. and Ford R. Lynch (Sep 24, 2003)
- Employment Agreement - Novavax Inc. and James R. Mirto (Jan 1, 2002)
- Employment Agreement - Novavax Inc. and John A. Spears (May 13, 1999)
- Employment Agreement - Novavax Inc. and Martin Arthur Heuer (Mar 4, 2002)
- Employment Agreement - Novavax Inc. and Nelson M. Sims (Aug 7, 2003)
- Employment Agreement - Novavax Inc. and Richard F. Maradie (Feb 26, 1997)
- Employment Agreement - Novavax Inc. and Richard J. Harwood (Mar 5, 1998)
- Employment Agreement - Novavax Inc. and Richard J. Harwood (Mar 5, 1999)
- Employment Agreement - Novavax Inc. and Thomas G. Tachovsky (Feb 23, 1998)
- Exclusive License and Distribution Agreement [Amendment No. 1] - King Pharmaceuticals Inc. and Novavax Inc. (Jun 29, 2001)
- Exclusive License and Distribution Agreement [Amendment No. 2] - King Pharmaceuticals Inc. and Novavax Inc. (Jun 29, 2001)
- Facility Reservation Agreement - Packaging Coordinators Inc. and Novavax Inc. (Jan 2002)
- License Agreement - Novavax Inc. and Cantab Pharmaceuticals Research Ltd. (Apr 22, 1999)
- License and Supply Agreement - Parkedale Pharmaceuticals Inc. and Novavax Inc. (Oct 21, 1999)
- MD-Columbia-8320 Guilford Road Lease - Rivers Center Associates LP and Novavax Inc. (Sep 25, 1996)
- MD-Rockville-12111/12115 Parklawn Drive Lease - Association for Entrepreneurial Sciences Inc. and Novavax Inc. (Mar 8, 2002)
- MD-Rockville-One Taft Court Lease - W.M. Rickman Construction Co. and Novavax Inc. (Sep 29, 1999)
- MO-Maryland Heights-11551 Adie Road Lease - GPG Enterprises LLC and The Fielding Pharmaceutical Co. (Sep 1, 2000)
- Pledge Agreement - Novavax Inc. and Mitchell J. Kelly (Mar 21, 2002)
- Secured Promissory Note - Novavax Inc. and Denis M. O'Donnell (Mar 21, 2002)
- Secured Promissory Note - Novavax Inc. and Mitchell J. Kelly (Mar 21, 2002)
- Security Agreement - Novavax Inc. and PIDC Local Development Corp. (Dec 20, 2002)
- Severance Agreement - Novavax Inc. and Richard F. Maradie (Sep 25, 1998)
Novo Nordisk A/S
Peregrine Pharmaceuticals Inc.
Pfizer Inc.
Pharmos Corp.
- Asset Purchase Agreement [Amendment No. 1] - Bausch & Lomb Inc. and Pharmos Corp. (Dec 28, 2001)
- Consulting Agreement - Pharmos Corp. and Alan M. Mark (Nov 11, 1996)
- Consulting Agreement - Pharmos Corp. and Elkan R. Gamzu (Jan 21, 2000)
- Consulting Agreement - Pharmos Corp. and Marvin P. Loeb (Apr 14, 2000)
- Consulting Agreement - Pharmos Corp. and Stephen C. Knight (Apr 7, 2000)
- Employment Agreement - Pharmos Corp. and Gad Riesenfeld (Apr 2, 2001)
- Employment Agreement - Pharmos Corp. and Haim Aviv (Apr 2, 2001)
- Employment Agreement - Pharmos Corp. and James A. Meer (Jul 12, 2004)
- Employment Agreement - Pharmos Corp. and Robert W. Cook (Dec 15, 1997)
- Employment Agreement - Pharmos Corp. and Robert W. Cook (Apr 2, 2001)
- Employment Agreement [Amendment] - Pharmos Corp. and Gad Riesenfeld (Apr 23, 2001)
- License Agreement - Pharmos Ltd. and Herbamed Ltd. (Dec 18, 2001)
- Marketing Agreement - Bausch & Lomb Pharmaceuticals Inc. and Pharmos Corp. (Jun 30, 1995)
- Marketing Agreement - Bausch & Lomb Pharmaceuticals inc. and Pharmos Corp. (Dec 12, 1996)
- Note Purchase Agreement - Millenium Partners LP and Pharmos Corp. (Feb 28, 2003)
- Note Purchase Agreement - St. Albans Partners Ltd. and Pharmos Corp. (Feb 28, 2003)
- Stock Purchase Agreement - Pharmos Corp. and Bausch & Lomb Pharmaceuticals Inc. (Dec 12, 1996)
Protein Design Labs Inc.
- Agreement - F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Oct 20, 1999)
- Agreement - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Oct 20, 1999)
- Agreement [Amendment No. 1] - F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Feb 23, 2001)
- Agreement [Amendment No. 2] - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd., and Protein Design Labs Inc. (Feb 23, 2001)
- Agreement [Amendment] - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design Labs Inc. (Jun 2, 2000)
- CA-Fremont-34801/34781 Campus Drive Agreement of Purchase and Sale - Ardenstone LLC and Protein Design Labs Inc. (Jun 1999)
- CA-Fremont-34810 Campus Drive Lease - Peery/Arrillaga and Protein Design Labs Inc. (Jun 28, 2001)
- CA-Fremont-Ardenwood Corporate Commons Lease - Ardenstone LLC and Protein Design Labs Inc. (Jul 1, 1997)
- CA-Sunnyvale-552 Del Rey Avenue Lease - Peery/Arrillaga and Protein Design Labs Inc. (Feb 20, 1997)
- Collaboration Agreement - Exelixis Inc. and Protein Design Labs Inc. (May 22, 2001)
- Development and License Agreement - Protein Design Labs Inc. and Sandoz Pharma Ltd. (Dec 1, 1990)
- Development and License Agreement - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
- Development and License Agreement - Protein Design Labs Inc. and Yamanouchi Pharmaceutical Co. Ltd. (Feb 12, 1991)
- Employment Agreement - Protein Design Labs Inc. and Laurence Jay Korn (May 1, 2002)
- Employment Agreement - Protein Design Labs Inc. and Mark McDade (Oct 24, 2002)
- Executive Retention and Severance Plan - Protein Design Labs Inc. (Oct 18, 2001)
- License Agreement - F. Hoffman-La Roche & Co. Ltd. and Protein Design Labs Inc. (Jan 31, 1989)
- License Agreement - Hoffman-La Roche Inc. and Protein Design Labs Inc. (Jan 31, 1989)
- License Agreement - National Technical Information Services and Protein Design Labs Inc. (Oct 12, 1988)
- License Agreement - Protein Design Labs Inc. and Sloan-Kettering Institute for Cancer Research (Nov 30, 1989)
- License Agreement - Stanford University and Protein Design Labs Inc. (Jul 1, 1990)
- License Agreement [Amendment No. 2] - Sloan-Kettering Institute for Cancer Research and Protein Design Labs Inc. (Jan 2, 1997)
- MN-Plymouth-3850 Annapolis Lane Lease - St. Paul Properties Inc. and Protein Design Labs Inc. (May 31, 2001)
- MN-Plymouth-3955 Annapolis Lane Lease [Amendment No. 3] - St. Paul Properties Inc. and Protein Design Labs Inc. (Nov 27, 1996)
- Manufacturing Agreement - ICOS Corp. and Protein Design Labs Inc. (Aug 29, 2003)
- Master Agreement - Protein Design Labs Inc. and Tanox Inc. (Mar 17, 2000)
- Note Purchase Agreement - Exelixis Inc. and Protein Design Labs Inc. (May 22, 2001)
- Patent License Agreement [IL-5] - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
- Patent License Agreement [RSV] - Protein Design Labs Inc. and MedImmune Inc. (Jul 17, 1997)
- Patent Licensing Master Agreement - Protein Design Labs Inc. and Genentech Inc. (Sep 25, 1998)
- Patent Rights Agreement - Protein Design Labs Inc. and SmithKline Beecham Corp. (Sep 28, 1999)
- Software License Agreement - Protein Design Labs Inc., Molecular Applications Group and Michael Levitt (Sep 1, 1990)
- Worldwide Agreement - Hoffman-La Roche Inc., F. Hoffman-La Roche Ltd. and Protein Design labs Inc. (Oct 1, 2003)
Quintiles Transnational Corp.
- Consulting Agreement - Quintiles Transnational Corp. and A. M. Pappas & Associates LLC (Jan 1, 2000)
- Data Rights Agreement - Healtheon/WebMD Corp. and Quintiles Transnational Corp. (May 26, 2000)
- Deed of Non-Competition - Quintiles Transnational Corp. and Barrie Stevens Haigh (Nov 29, 1996)
- Deed of Non-Competition - Quintiles Transnational Corp. and David F. White (Nov 29, 1996)
- Deed of Non-Competition - Quintiles Transnational Corp. and Paul Knott (Nov 29, 1996)
- Employment Agreement - ENVOY Corp. and Jim D. Kever (Mar 30, 1999)
- Employment Agreement - Quintiles Transnational Corp. and Barrie Stevens Haigh (Nov 29, 1996)
- Employment Agreement - Quintiles Transnational Corp. and James L. Bierman (Jan 21, 2004)
- Employment Agreement - The Lewin Group Inc. and Lawrence S. Lewin (May 13, 1996)
- Executive Employment Agreement - Quintiles Inc. and Ludo Reynders (Mar 17, 2000)
- Executive Employment Agreement - Quintiles Transnational Corp. and James L. Bierman (Jun 16, 1998)
- Executive Employment Agreement - Quintiles Transnational Corp. and John D. Ratliff (Jun 14, 2004)
- Executive Employment Agreement - Quintiles Transnational Corp. and John S. Russell (Dec 3, 1998)
- Executive Employment Agreement - Quintiles Transnational Corp. and Oppel Greeff (Feb 8, 2002)
- Executive Employment Agreement - Quintiles Transnational Corp. and Pamela Josephine Kirby (Mar 13, 2001)
- Executive Employment Agreement - Quintiles Transnational Corp. and Ron Wooten (Jul 25, 2000)
- Executive Employment Agreement - Quintiles Transnational Corp. and Santo J. Costa (Nov 30, 1999)
- Executive Employment Agreement - Quintiles Transnational Corp., Pharma Services Holding Inc. and Dennis B. Gillings (Sep 25, 2003)
- Executive Employment Agreement [Amendment No. 2] - Quintiles Transational Corp. and Dennis B. Gillings (Apr 1, 2001)
- Executive Employment Agreement [Amendment] - ENVOY Corp. and Jim D. Kever (Nov 23, 1999)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and Dennis B. Gillings (Oct 26, 1999)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and James L. Bierman (Mar 31, 2003)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and John S. Russell (Oct 26, 1999)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and John S. Russell (Nov 14, 2003)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and Oppel Greeff (Nov 17, 2003)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and Oppel Greeff (Dec 5, 2003)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and Rachel R. Selisker (Oct 25, 1999)
- Executive Employment Agreement [Amendment] - Quintiles Transnational Corp. and Ron Wooten (Nov 5, 2003)
- Independent Consultant Agreement - Quintiles Transnational Corp. and Santo J. Costa (Nov 20, 2001)
- Internet Product Development and Marketing Agreement - Healtheon/WebMD Corp. and Quintiles Transnational Corp. (May 26, 2000)
- KS-Lenexa-15705 College Boulevard Lease - Lenexa Industrial Park Inc. and Innovex Inc. (Nov 30, 1995)
- Master Consulting Agreement - Interneuron Pharmaceuticals Inc. and Quintiles Inc. (Jul 12, 1996)
- Master Services Agreement - Cubist Pharmaceuticals Inc. and Quintiles Inc. (Apr 25, 2001)
- Master Services Agreement - Quintiles Transnational Corp. and A. M. Pappas & Associates LLC (Jan 1, 2001)
- NJ-Parsippany-9 Campus Drive Lease - Legent Corp. and Innovex Inc. (Jan 18, 1996)
- NJ-Parsippany-9 Campus Drive Lease - Prubeta-3 and Innovex Inc. (Jan 31, 1997)
- Service Agreement - Innovex Holdings Ltd. and Paul Knott (Mar 31, 1993)
- Service Agreement - Innovex plc and David Findlay White (Sep 2, 1994)
- Settlement Agreement - Quintiles Transnational Corp., WebMD Corp. and ENVOY Corp. (Oct 12, 2001)
- South Africa-Belleville-Rosenpark-2 Bella Rosa Street Lease - Rosenpark Eiendomme CC and Quintiles Clindepharm (Pty) Ltd. (Dec 21, 2000)
- South Africa-Centurion-Lyttelton Manor X 3-Erf 1831 Lease - Shibbolet (Pty) Ltd. and Quintiles Clindepharm (Pty) Ltd. (Dec 7, 1999)
- Stock Purchase Agreement - Pharma Services Holding Inc. and Oppel Greeff (Oct 30, 2003)
- UK-Berkshire-Bracknell-High Street and The Ring Lease - The Norwich Union Life Insurance Society, Quintiles (UK) Ltd. and Quintiles Transnational Corp. (Dec 20, 1996)
- UK-Bracknell-Market Street-Station House Lease - PDFM Ltd., Quintiles (UK) Ltd. and Quintiles Transnational Corp. (Nov 28, 1997)
- UK-Buckinghamshire-Marlow-Globe Park-Fieldhouse Lane-Solar House Lease - Seagate Technology Inc. and Innovex Holdings Ltd. (Nov 6, 1996)
- Work Order - Cubist Pharmaceuticals Inc. and Quintiles Inc. (Jun 7, 2001)
Rigel Pharmaceuticals Inc.
- CA-South San Francisco-240 East Grand Avenue Lease [Termination] - Britannia Pointe Grand LP and Rigel Pharmaceuticals Inc. (May 16, 2001)
- CA-South San Francisco-Britannia Pointe Grand Business Park Lease - Britannia Pointe Grand LP and Rigel Inc. (Jun 2, 1998)
- Collaboration Agreement - Rigel Pharmaceuticals Inc. and Daiichi Pharmaceutical Co. Ltd. (Aug 1, 2000)
- Collaboration Agreement - Rigel Pharmaceuticals Inc. and Janssen Pharmaceutica NV (Dec 4, 1998)
- Collaboration Agreement - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (May 26, 1999)
- Collaboration Agreement [Amendment No. 1] - Rigel Pharmaceuticals Inc. and Janssen Pharmaceutica NV (Jun 30, 2000)
- Collaboration Agreement [Amendment No. 1] - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (May 18, 2001)
- Collaboration Agreement [Amendment No. 2] - Rigel Pharmaceuticals Inc. and Janssen Pharmaceutica NV (Dec 4, 2001)
- Collaboration Agreement [Amendment No. 2] - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (Jul 6, 2001)
- Collaborative Research and Development Agreement - Neurocrine Biosciences Inc. and Rigel Inc. (Dec 1997)
- Collaborative Research and License Agreement - Pfizer Inc. and Rigel Pharmaceuticals Inc. (Jan 31, 1999)
- Employment Agreement - Rigel Pharmaceuticals Inc. and Donald G. Payan (Jan 16, 1997)
- Employment Agreement - Rigel Pharmaceuticals Inc. and Elliott B. Grossbard (Mar 18, 2002)
- License Agreement - Stanford University and Rigel Pharmaceuticals Inc. (Oct 7, 1996)
- License Agreement - Stanford University and Rigel Pharmaceuticals Inc. (Aug 18, 1997)
- License Agreement - Stanford University and Rigel Pharmaceuticals Inc. (Mar 27, 1998)
- License and Research Agreement - Rigel Pharmaceuticals Inc. and Cell Genesys Inc. (Sep 2, 1999)
- License and Research Agreement - Rigel Pharmaceuticals Inc. and Cell Genesys Inc. (Mar 26, 2001)
- License and Research Agreement - Rigel Pharmaceuticals Inc. and Cell Genesys Inc. (Jul 1, 2001)
- Master Equipment Lease Agreement - Lighthouse Capital Partners IV LP and Rigel Pharmaceuticals Inc. (Dec 23, 2002)
- Technology Transfer Agreement - Rigel Pharmaceuticals Inc. and Questcor Pharmaceuticals Inc. (Sep 22, 2000)
Salmedix Inc.
- CA-San Diego-9380 Judicial Drive Sublease - Idun Pharmaceuticals INc. and Salmedix Inc. (Dec 6, 2002)
- CA-San Diego-9381 Judicial Drive Lease - University Center East LLC and Salmedix Inc. (Sep 14, 2004)
- Consulting Agreement - Salmedix Inc. and Antonio J. Grillo-Lopez (May 9, 2001)
- Consulting Agreement - Salmedix Inc. and Dennis Carson (Dec 1, 2000)
- Employment Agreement - Salmedix Inc. and David S. Kabakoff (Aug 7, 2001)
- Exclusive License Agreement - University of California and Salmedix Inc. (Sep 21, 2001)
- General Release of All Claims - Salmedix Inc. and F. Andrew Dorr (Aug 6, 2004)
- Global Services Agreement - AMCIS AG, Fujisawa Deutschland GmbH and Salmedix Inc. (Apr 23, 2004)
- License Agreement - FUJISAWA Deutschland GmbH and SALMEDIX Inc. (May 1, 2003)
Sandoz Ltd.
Sanofi-Synthelabo
Santarus Inc.
- 1998 Stock Option Plan - Santarus Inc. (Dec 3, 2003)
- 2004 Equity Incentive Award Plan - Santarus Inc. (2004)
- Bylaws - Santarus Inc.
- CA-San Diego-10590 West Ocean Air Drive Lease - Torrey View Associates LP and Santarus Inc. (Aug 24, 2001)
- Capital Reimbursement Agreement - Patheon Inc. and Santarus Inc. (Dec 19, 2003)
- Certificate of Incorporation - Santarus Inc. (Apr 6, 2004)
- Employee Stock Purchase Plan - Santarus Inc. (Mar 31, 2004)
- Employment Agreement - Santarus Inc. and Bonnie Hepburn (Mar 31, 2004)
- Employment Agreement - Santarus Inc. and Debra P. Crawford (Mar 31, 2004)
- Employment Agreement - Santarus Inc. and Gerald T. Proehl (Mar 31, 2004)
- Employment Agreement - Santarus Inc. and Julie A. DeMeules (Mar 31, 2004)
- Employment Agreement - Santarus Inc. and Warren E. Hall (Mar 31, 2004)
- Employment Agreement - Santarus Inc. and William C. Denby III (Mar 31, 2004)
- Exclusive License Agreement - University of Missouri and Santarus Inc. (Jan 26, 2001)
- Exclusive License Agreement [Amendment No. 1] - University of Missouri and Santarus Inc. (Jan 26, 2001)
- Indemnification Agreement - Santarus Inc. (2004)
- License Agreement - Santarus Inc., TAP Pharmaceutical Products Inc. and Takeda Chemical Industries Ltd. (Jun 27, 2002)
- Manufacturing and Supply Agreement - Santarus Inc. and Patheon Inc. (Dec 19, 2003)
- Omeprazole Supply Agreement - Santarus Inc., Interchem Trading Corp. d/b/a Interchem Corp. and Union Quimico Farmaceutica SA (Sep 25, 2003)
- Stock Purchase Agreement - Santarus Inc. and University of Missouri (Jan 26, 2001)
- Stock Restriction and Registration Rights Agreement - Santarus Inc. and University of Missouri (Jan 26, 2001)
- Warrant to Purchase Shares of Common Stock - Santarus Inc. and Rockport Venture Securities LLC (Apr 30, 2003)
Schering AG
Schering-Plough Corp.
- Collaboration and License Agreement - Pharmacopeia Inc. and Schering Corp. (Oct 29, 1998)
- Collaboration and License Agreement - Pharmacopeia Inc. and Schering-Plough Inc. (Jul 9, 2003)
- Collaboration and License Agreement - Pharmacopeia Inc. and Schering-Plough Ltd. (Oct 29, 1998)
- Collaborative Agreements, GEM Services Agreement and Custom Sequencing Services Agreement [Termination] - Incyte Genomics Inc. and Schering-Plough Ltd. (Sep 5, 2002)
- Exclusive License Agreement - Sepracor Inc. and Schering-Plough Ltd. (Dec 5, 1997)
- Gene Therapy Collaboration and License - Human Genome Sciences Inc., Schering Corp. and Schering Plough Ltd. (Jun 28, 1996)
- Therapeutic Collaboration and License Agreement - Human Genome Sciences Inc., Schering Corp., Schering Plough Ltd., SmithKline Beecham Corp. and SmithKline Beecham plc (Jun 28, 1996)
Senomyx Inc.
- CA-La Jolla-11099 North Torrey Pines Road Lease - Health Science Properties Inc. and Sequana Therapeutics Inc. (Jul 12, 2000)
- CA-La Jolla-11099 North Torrey Pines Road Sublease - Senomyx Inc. and Akkadix Corp. (Jul 17, 2000)
- CA-La Jolla-11099 North Torrey Pines Road Sublease - Sequana Therapeutics Inc. d/b/a Axys Pharmaceuticals Inc. and PPGx Inc. (Feb 1, 1999)
- Collaborative Research and License Agreement - Senomyx Inc. and Aurora Biosciences Corp. (Apr 16, 2002)
- Collaborative Research and License Agreement - Senomyx Inc. and Campbell Soup Co. (Mar 28, 2001)
- Collaborative Research and License Agreement - Senomyx Inc. and Kraft Foods Inc. (May 2, 2002)
- Collaborative Research and License Agreement - Senomyx Inc. and NESTEC Ltd. (Oct 23, 2003)
- Collaborative Research and License Agreement - Senomyx Inc. and NESTEC Ltd. (Oct 26, 2004)
- Collaborative Research, Development, Commercialization and License Agreement - Senomyx Inc. and Coca-Cola Co. (Apr 22, 2002)
- Consulting Agreement - Ambryx Inc. and Lubert Stryer (Apr 15, 1999)
- Employee Proprietary Information and Inventions Agreement - Senomyx Inc.
- Employment Agreement - Ambryx Inc. and Jean J. Lockhart (Oct 24, 1999)
- Employment Agreement - Ambryx Inc. and Lubert Stryer (May 25, 1999)
- Employment Agreement - Ambryx Inc. and Mark J. Zoller (Feb 21, 2000)
- Employment Agreement - Senomyx Inc. and Harry Leonhardt (Aug 25, 2003)
- Employment Agreement - Senomyx Inc. and John Poyhonen (Sep 8, 2003)
- Employment Agreement - Senomyx Inc. and Klaus Gubernator (Jun 7, 2000)
- Employment Agreement - Senomyx Inc. and Paul A. Grayson (Feb 8, 2001)
- Employment Agreement - Senomyx Inc. and R. Kent. Snyder (Jun 2, 2003)
- Exclusive License and Bailment Agreement - University of California and Ambryx Inc. (Mar 10, 2000)
- LifeSeq Collaborative Agreement - Incyte Genomics Inc. and Senomyx Inc. (Dec 29, 2000)
- Promissory Note - Ambryx Inc. and Jean Lockhart (Feb 20, 2000)
Sepracor Inc.
- 2002 Stock Incentive Plan - Sepracor Inc. (Jun 13, 2002)
- Agreement - Minnesota Mining and Manufacture Co., 3M Innovative Properties Co. and Sepracor Inc. (Dec 20, 2001)
- Assignment Agreement - Sepracor Inc. and Georgetown University (Aug 25, 1999)
- Co-Promotion Agreement - Abbott Laboratories Inc. and Sepracor Inc. (Nov 19, 1999)
- Consulting Agreement - Sepracor Inc. and Alan Steigrod (Sep 1, 1996)
- Consulting Agreement - Sepracor Inc. and Digby W. Barrios (Oct 1, 1995)
- Consulting Agreement - Sepracor Inc. and Keith Mansord (Feb 1, 1996)
- Consulting Agreement [Amendment] - Sepracor Inc. and Alan Steigrod (Jan 1, 1997)
- Employment Agreement - Sepracor Inc. and James O'Shea (Sep 10, 1999)
- Employment Agreement - Sepracor Inc. and Mark H. N. Corrigan (Mar 11, 2003)
- Employment Agreement - Sepracor Inc. and Paul D. Rubin (Feb 23, 1996)
- Employment Agreement - Sepracor Inc. and Robert F. Scumaci (Feb 23, 1995)
- Exclusive License Agreement - Eli Lilly & Co. and Sepracor Inc. (Dec 4, 1998)
- Exclusive License Agreement - Sepracor Inc. and Schering-Plough Ltd. (Dec 5, 1997)
- License Agreement - Sepracor Inc. and Hoechst Marion Roussel Inc. (Aug 31, 1999)
- License Agreement - Sepracor Inc. and Hoechst Marion Roussel Inc. (Aug 31, 1999)
- License Agreement for Levocetirizine - UCB Farchim SA and Sepracor Inc. (May 27, 1999)
- License and Assignment Agreement - Sepracor Inc. and Rhone-Poulenc Rorer SA (Sep 30, 1999)
- Loan Agreement [Lien No. 1] - Waterford Park LLC and Sepracor Inc. (Jan 30, 2001)
- Loan Agreement [Lien No. 2] - Waterford Park LLC and Sepracor Inc. (Jan 30, 2001)
- MA-Marlboro-111 Locke Drive Lease [Amendment No. 1] - Second Marlborough Development Trust and Sepracor Inc. (Jul 1, 1997)
- MA-Marlborough-Solomon Pond Corporate Center Lease - Waterford Park LLC and Sepracor Inc. (Jan 30, 2001)
- MA-Marlborough-Solomon Pond Corporate Center Leasehold Mortgage and Security Agreement [Mortgage No. 1] - Waterford Park LLC and Sepracor Inc. (Jan 30, 2001)
- MA-Marlborough-Solomon Pond Corporate Center Leasehold Mortgage and Security Agreement [Mortgage No. 2] - Waterford Park LLC and Sepracor Inc. (Jan 30, 2001)
- Norastemizole Collaboration and License Agreement - Sepracor Inc. and Janssen Pharmaceutica NV (Jan 30, 1998)
- Norcisapride Development and License Agreement - Sepracor Inc. and Janssen Pharmaceutica NV (Jul 20, 1998)
- Note - Waterford Park LLC and Sepracor Inc. (Jan 30, 2000)
- Note - Waterford Park LLC and Sepracor Inc. (Jan 30, 2001)
- Promissory Note - Sepracor Inc. and David Barlow (Jun 15, 1996)
- Promissory Note - Sepracor Inc. and David Barlow (Dec 18, 1997)
- Promissory Note - Sepracor Inc. and Paul D. Rubin (Jan 22, 1998)
- Promissory Note - Sepracor Inc. and Paul Rubin (May 23, 1997)
- Revolving Credit Agreement - Fleet National Bank, Sepracor Inc. and Biosphere Medical Inc. (Dec 22, 1999)
- Stock Purchase Agreement - Sepracor Inc. and Marion Merrell Dow Inc. (Jun 1, 1993)
- Stock Purchase Agreement - Sepracor Inc. and OFD Partners LP (Sep 30, 1994)
- Technology Transfer and License Agreement - Sepracor Inc. and BioSepra Inc. (Jan 1, 1994)
- Technology Transfer and License Agreement - Sepracor Inc. and HemaSure Inc. (Jan 1, 1994)
- Technology Transfer and License Agreement - Sepracor Inc. and Seprachem Inc. (Jan 1, 1995)
Sequenom Inc.
- Beta Test Agreement - Sequenom Inc. and GLE Medicon GmbH (Mar 1, 1999)
- Beta Test Agreement - Sequenom Inc. and Harald Funke (Apr 1999)
- Beta Test Agreement - Sequenom inc. and Genzyme Corp. (Jul 15, 1999)
- CA-San Diego-11555 Sorrento Valley Road Lease - Sorrento Business Complex and Sequenom Inc. (Dec 12, 1996)
- Collaboration Agreement - Bruker-Franzen Anajytik GmbH and Sequenom Instruments GmbH (Nov 24, 1997)
- Commercial Promissory Note - Union Bank of California NA and Sequenom Inc. (Mar 3, 2000)
- Consulting Services Agreement - Sequenom Inc. and John Cashman (Mar 1, 1999)
- Consulting Services Agreement - Sequenom Inc. and Lindsay Farrer (Mar 1, 1999)
- Consulting Services Agreement - Sequenom Inc. and Sequenom Instruments GmbH and Peter Roepstorff (Jan 30, 1997)
- Consulting Services Agreement - Sequenom Inc. and Ulf. B. Gobel (Feb 17, 1997)
- Consulting Services Agreement - Sequenom Inc., Sequenom Instruments GmbH and Franza Hillenkamp (Oct 4, 1996)
- Contractual Agreement - Sequenom Inc. and GeSiM (Oct 1, 1998)
- Cooperation Agreement - Sequenom Inc. and Technologie Beteiligungs Gesellschaft mbH of the Deutsche Ausgleichsbank
- Cooperative Research and Development Agreement - National Human Genome Research Institute and Sequenom Inc. (Sep 23, 1999)
- Diagnostic Platform Benchmarking Study and Evaluation Agreement - Sequenom Inc. and Siemens AG (Oct 25, 2004)
- Employment Agreement - Sequenom Inc. and Andi Braun (Aug 1, 2000)
- Employment Agreement - Sequenom Inc. and Charles Cantor (Nov 16, 1999)
- Employment Agreement - Sequenom Inc. and Delbert F. Foit Jr. (Aug 1, 2000)
- Employment Agreement - Sequenom Inc. and Hubert Koster (Dec 22, 1997)
- Employment Agreement - Sequenom Inc. and Paul Heaney (May 13, 1999)
- Employment Agreement - Sequenom Inc. and Steve Zaniboni (Aug 1, 2000)
- Employment Agreement - Sequenom Inc. and Toni Schuh (Jun 1, 2000)
- Extramural Agreement - United States Department of Agriculture and Sequenom Inc. (Jun 15, 1999)
- Global Master Rental Agreement - Comdisco Inc. and Sequenom Inc. (May 4, 2000)
- High Throughput Oligonucleotide Manufacturing and Supply and MassARRAY(TM) Analytical System Purchase Agreement - Sequenom Inc. and Integrated DNA Technologies Inc. (Aug 24, 2000)
- Investment Contract - Sequenom Instruments GmbH and Technologie-Beteiligung-Gesellschaft mbH of Deutsche Ausgleichsbank (Jun 23, 1995)
- License Agreement - Franz Hillenkamp and Sequenom Inc. (Jun 1999)
- License Agreement - Johns Hopkins University and Sequenom Inc. (Jul 3, 1997)
- MA-Sudbury-142 F North Road Lease - Cummings Properties LLC and Sequenom Inc. (Aug 1, 1999)
- Manager Employment Contract - Sequenom Gesellschaft fur Genomanalytik mbH and Karsten Schmidt (Apr 30, 1999)
- MassARRAY(TM) Core Facility Contract Terms - Sequenom Inc. and Hitachi Ltd. Life Science Group (Dec 11, 2000)
- MassARRAY(TM) Distribution Contract Terms - Sequenom Inc. and Nissei Sangyo Co. Ltd. (Dec 11, 2000)
- Master Equipment Lease Agreement - Phoenix Leasing Inc. and Sequenom Inc. (Feb 5, 1998)
- Note Secured By Stock Pledge Agreement - Sequenom Inc. and Andreas Braun (Nov 30, 2000)
- Note Secured By Stock Pledge Agreement - Sequenom Inc. and Antonius Schuh (Nov 30, 2000)
- Note Secured By Stock Pledge Agreement - Sequenom Inc. and Stephen L. Zaniboni (Nov 30, 2000)
- OEM Supply & License Agreement - PerSeptive Biosystems Inc. and Sequenom Inc. (Jun 15, 1999)
- OEM Supply Agreement - Beckman Coulter Inc. and Sequenom Inc. (1999)
- Patent and Know-How License Agreement - Boston University and Sequenom Inc. (Jun 1, 1996)
- Purchase and License Agreement - Specialty Laboratories and Sequenom Inc. (Jun 20, 2000)
- Research Agreement - Boston University and Sequenom Inc. (Oct 8, 1997)
- Research Collaboration and License Agreement - Sequenom Inc., Glaxo Group Ltd. and SmithKline Beecham Corp. (Aug 23, 2001)
- Retirement Agreement and General Release Of All Claims - Sequenom Inc. and Delbert F. Foit Jr. (Dec 2, 2002)
- Settlement Agreement - Sequenom Inc. and Hubert Koster (Jun 6, 2000)
- Sponsored Research Agreement - Boston University and Sequenom Inc. (Sep 15, 1994)
- Sponsored Research Agreement - Boston University and Sequenom Inc. (Oct 1, 1999)
- Strategic Alliance Agreement - Genaissance Pharmaceuticals Inc. and Sequenom Inc. (May 3, 2000)
- Supply Agreement - Sequenom Instruments GmbH and Bertram Mhller-Myhsok (Jul 8, 1997)
- Supply Agreement - Tactical Fabs Inc. and Sequenom Inc. (Apr 1, 1999)
- Technology Access and Collaboration Agreement - Sequenom Inc. and Incyte Genomics Inc. (Sep 29, 2000)
- Technology Access and Collaboration Agreement [Addendum] - Sequenom Inc. and Incyte Genomics Inc.
StemCells Inc.
- Agreement - StemCells Inc., Millenium Partners LP and Riverview Group LLC (Dec 4, 2001)
- Agreement and Plan of Merger - CytoTherapeutics Inc. and StemCells Inc. (Aug 13, 1997)
- Agreement for Consulting Services - CytoTherapeutics Inc. and Edwin C. Cadman (Sep 2, 1996)
- Agreement for Consulting Services - CytoTherapeutics Inc. and Peter Simon (Dec 1, 1996)
- Asset Purchase and License Agreement - CytoTherapeutics Inc. and Neurotech SA (Dec 29, 1999)
- CA-Palo Alto-3155 Porter Drive Lease - Stanford University and StemCells Inc. (Feb 1, 2001)
- Consulting Agreement - CytoTherapeutics Inc. and Irving Weissman (Sep 25, 1997)
- Consulting Agreement - CytoTherapeutics Inc. and Seth A. Rudnick (Sep 30, 1997)
- Consulting Services Agreement - CytoTherapeutics Inc. and John Schwartz (Jul 27, 1998)
- Convertible Loan Agreement - Modex Therapeutiques SA and CytoTherapeutics Inc. (Jul 10, 1996)
- Cross License Agreement - CytoTherapeutics Inc. and Modex Therapeutics SA (Jul 10, 1996)
- Cross License Agreement - CytoTherapeutics inc. and Modex Therapeutics SA (Oct 29, 1997)
- Development Collaboration and License Agreement - Genetech Inc. and CytoTherapeutics Inc. (Nov 22, 1996)
- Director's Agreement - CytoTherapeutics Inc. and John Schwartz (Dec 19, 1998)
- Employment Agreement - CytoTherapeutics Inc. and Billie M. York (Mar 20, 1998)
- Employment Agreement - CytoTherapeutics Inc. and John S. McBride (Apr 17, 1997)
- Employment Agreement - CytoTherapeutics Inc. and John Schwartz (Jul 1, 1999)
- Employment Agreement - CytoTherapeutics Inc. and Philip K. Yachmetz (Jun 8, 1998)
- Employment Agreement - CytoTherapeutics Inc. and Philip K. Yachmetz (Jun 8, 1999)
- Employment Agreement - CytoTherapeutics Inc. and Richard M. Rose (Sep 25, 1997)
- Employment Agreement - CytoTherapeutics Inc. and Sandra Nusinoff Lehrman (Jul 2, 1996)
- Employment Agreement - StemCells Inc. and George Dunbar (Nov 17, 1999)
- Employment Agreement - StemCells Inc. and Martin McGlynn (Jan 2, 2001)
- License Agreement - StemCells Inc., Neurospheres Ltd. and Neurospheres Holdings Ltd. (Oct 30, 2000)
- License Agreement - The Scripps Research Institute and StemCells Inc. (Jun 1999)
- License Agreement 98-058 - The Scripps Research Institute and StemCells Inc. (Oct 1998)
- License Agreement 98-086 - The Scripps Research Institute and StemCells Inc. (Oct 1998)
- License Agreement 98-126 - The Scripps Research and StemCells Inc. (Nov 1998)
- Option Agreement - CytoTherapeutics Inc. and Societe Financiere Valoria SA (Jul 10, 1996)
- Registration Rights Agreement - StemCells Inc. and Riverview Group LLC (Dec 4, 2001)
- Research Agreement - CytoTherapeutics Inc., Irving L. Weissman and Fred H. Gage
- Securities Purchase Agreement - StemCells Inc. (Jun 16, 2004)
- Services Agreement - CytoTherapeutics Inc. and iCEO LLC (Nov 17, 1999)
- Severance Agreement - CytoTherapeutics Inc. and E. Edward Baetge (Jul 29, 1997)
- Severance Agreement - CytoTherapeutics Inc. and Moses Goddard (Aug 30, 1999)
- Severance Agreement - CytoTherapeutics Inc. and Sandra Nusinoff Lehrman (Jul 21, 1997)
- Subscription Agreement - StemCells Inc. and Millenium Partners LP (Dec 4, 2001)
SuperGen Inc.
- Agreement to Terminate and Release of Collateral - SuperGen Inc. and Tako Ventures LLC (Sep 30, 1999)
- Asset Purchase Agreement - AMUR Pharmaceuticals Inc. and SuperGen Inc. (Feb 18, 2000)
- Asset Purchase Agreement - Immunex Corp. and SuperGen Inc. (Jan 15, 1997)
- CA-Dublin-4130 Dublin Boulevard Lease - Koll Dublin Corporate Center LP and SuperGen Inc. (Jun 23, 2000)
- CA-Pleasanton-1059 Serpentine Lane Standard Offer, Agreement and Escrow Instructions for Purchase of Real Estate - SuperGen Inc. and Ashwill Trust (Dec 11, 1996)
- CA-Pleasanton-1075 Serpentine Lane-Suite A Lease - Sea Cliff Properties and SuperGen Inc. (Feb 12, 1999)
- CA-Pleasanton-1075 Serpentine Lane-Suite B Lease - Sea Cliff Properties and SuperGen Inc. (Feb 12, 1999)
- CA-San Ramon-2 Annabel Lane Lease - Annabel Investment Co. and SuperGen Inc. (Oct 14, 1996)
- Common Stock Purchase Agreement - SuperGen Inc. and HSBC James Capel Canada Inc. (Nov 23, 1998)
- Common Stock Purchase Warrant - SuperGen Inc. and Tako Ventures LLC (Mar 25, 1999)
- Common Stock Sale/Repurchase Agreement - Israel Chemicals Ltd. and SuperGen Inc. (Aug 6, 1997)
- Common Stock Sale/Repurchase Agreement [Amendment No. 1] - Israel Chemicals Ltd. and SuperGen Inc. (Nov 12, 1997)
- Common Stock and Warrant Purchase Agreement - SuperGen Inc. and AVI BioPharma Inc. (Apr 4, 2000)
- Convertible Secured Note, Option and Warrant Purchase Agreement [Amendment No. 1] - SuperGen Inc. and Tako Ventures LLC (Mar 17, 1999)
- Drug Substance Validation and Supply Agreement - SuperGen Inc. (Jul 2, 2003)
- Employment, Confidential Information and Invention Assignment Agreement - SuperGen Inc. and Joseph Rubinfeld (Jan 1, 1998)
- Employment, Confidential Information, Invention Assignment, and Arbitration Agreement - SuperGen Inc. and Joseph Rubinfeld (Dec 31, 2003)
- Executive Employment and Confidential Information and Invention Assignment Agreement - SuperGen Inc. and James S. Manuso (Jan 1, 2004)
- Executive Employment, Confidential Information, Invention Assignment, and Arbitration Agreement - SuperGen Inc. and Joseph Rubinfeld (Mar 1, 2002)
- Know-How Transfer and Cooperation Agreement - Pharmachemie BV and SuperGen Inc. (Sep 10, 1999)
- License Agreement - Inflazyme Pharmaceuticals Ltd. and SuperGen Inc. (Apr 11, 1997)
- License Agreement - Peregrine Pharmaceuticals Inc. and SuperGen Inc. (Feb 13, 2001)
- License Agreement for Camptothecin - Research Development Foundation and SuperGen Inc. (Nov 15, 1999)
- License Agreement for Paclitaxel - Research Development Foundation and SuperGen Inc. (Nov 15, 1999)
- Non-Exclusive Supply Agreement - Supergen Inc. (May 7, 1997)
- Patent and Intellectual Property Assignment Agreement - SuperGen Inc. and AMUR Pharmaceuticals Inc. (Sep 27, 2000)
- Registration Rights Agreement - SuperGen Inc. (Nov 23, 1998)
- Registration Rights Agreement - SuperGen Inc. and HSBC James Capel Canada Inc. (Nov 23, 1998)
- Research Agreement for Camptothecin - Clayton Foundation for Research, Research Development Foundation and SuperGen Inc. (Nov 15, 1999)
- Research Agreement for Paclitaxel - Clayton Foundation for Research, Research Development Foundation and SuperGen Inc. (Nov 15, 1999)
- Sales, Distribution, and Development Agreement - AVI BioPharma Inc. and SuperGen Inc. (Apr 4, 2000)
- Secured Promissory Note - SuperGen Inc. and Tako Ventures LLC (Mar 25, 1999)
- Stock Purchase Agreement - SuperGen Inc. and Tako Ventures LLC (Jan 29, 1999)
- Supply Agreement for Pentostatin - Hauser Technical Services Inc. and SuperGen Inc. (Dec 13, 2002)
- Supply and Distribution Agreement - SuperGen Inc. and EuroGen Pharmaceuticals Ltd. (Sep 21, 2001)
- Warrant - SuperGen Inc. and Paul Revere LLC (Jun 24, 2003)
Syntex Corp.
Taisho Pharmaceutical Co. Ltd.
Tanox Inc.
- Ancillary Development & Licensing Agreement - Novartis Pharma AG and Tanox Inc. (Feb 25, 2004)
- Asset Purchase and License Agreement - Sunol Molecular Corp. and Tanox Inc. (Mar 25, 2005)
- CA-San Diego-11011 Torreyana Road Lease Assignment and Asset Purchase Agreement - Tanox West Inc. and Biogen Idec Inc. (Dec 9, 2004)
- Development and Licensing Agreement - Tanox Biosystems Inc. and Ciba-Geigy Ltd. (May 11, 1990)
- Development and Licensing Agreement - Tanox Inc. and Novartis Pharma AG (Feb 25, 2004)
- G-CSF Receptor Non-Exclusive License Agreement - Immunex Corp. and Tanox Inc. (Jan 11, 2000)
- Indemnification Agreement - Tanox Inc. (2000)
- License Agreement - Biogen Inc. and Tanox Biosystems Inc. (Jun 1, 1998)
- Master Agreement - Protein Design Labs Inc. and Tanox Inc. (Mar 17, 2000)
- Material Transfer and Commercial Evaluation Agreement - Tanox Inc. and Biovation Ltd. (Mar 9, 1999)
- Research and Development License and Options for Commercial License - PanGenetics BV, Panorama Research Inc., Mark de Boer and Chiron Corp. (Sep 25, 1995)
- Research and Licence Agreement - Tanox Inc. and Biovation Ltd. (Apr 21, 1999)
- Settlement Agreement - Genentech Inc., Genentech International Ltd., Tanox Biosystems Inc. and Ciba-Geigy Ltd. (Jul 8, 1996)
- Settlement and Cross-License Agreement [Amendment No. 1] - Genentech Inc. and Tanox Inc. (Feb 25, 2004)
- Settlement and Cross-Licensing Agreement - Tanox Biosystems Inc. and Genetech Inc. and Genentech International Ltd. (Jul 8, 1996)
- Settlement and Participation Agreement - Tanox Biosystems Inc. and F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., Roche Holding Ltd. and Roche Holdings Inc. (Jul 8, 1996)
- Stock Purchase Agreement - Tanox Biosystems Inc. and PanGenetics BV (Mar 12, 1998)
- Stock Purchase Agreement - Tanox Biosystems Inc., Tse Wen Chang, Nancy T. Chang, Alafi Capital Co., Shireen Alafi, Joseph Heskel and Invitron Corp. (Jul 14, 1987)
- Supplemental Agreement - Tanox Biosystems Inc. and Ciba-Geigy Ltd. (Jun 10, 1996)
- TX-Houston-10301 Stella Link Lease - Main Link Business Park Associates and Tanox Biosystems Inc. (Dec 4, 1986)
- Term Sheet for Secured Loan - Ciba-Geigy Ltd. and Tanox Biosystems Inc. (Dec 13, 1994)
- Tripartite Cooperation Agreement - Novartis Pharma AG, Genentech Inc. and Tanox Inc. (Feb 25, 2004)
Techne Corp.
Tercica Inc.
- CA-South San Francisco-651 Gateway Boulevard Lease - Gateway Center LLC and Tercica Medica Inc. (Jul 24, 2003)
- CA-South San Francisco-651 Gateway Boulevard Sublease - Elan Pharmaceuticals Inc. and Tercica Medica Inc. (Jun 24, 2002)
- CA-South San Francisco-651 Gateway Boulevard Sublease - Elan Pharmaceuticals Inc. and Tercica Medica Inc. (Mar 21, 2003)
- Employment Agreement - Tercica Inc. and Stephen Rosenfield (Jun 23, 2004)
- Employment Agreement - Tercica Inc. and Susan S. Wong (Jan 9, 2004)
- Employment Agreement - Tercica Inc. and Thomas H. Silberg (Apr 14, 2004)
- Employment Agreement - Tercica Inc. and Thorsten Von Stein (Dec 3, 2004)
- Employment Agreement - Tercica Medica Inc. and Andrew Grethlein (Mar 5, 2003)
- Employment Agreement - Tercica Medica Inc. and George Bright (Jun 4, 2003)
- Employment Agreement - Tercica Medica Inc. and Ira Wallis (Feb 24, 2003)
- Employment Agreement - Tercica Medica Inc. and Mike Parker (Dec 9, 2002)
- Employment Agreement - Tercica Medica Inc. and Ross G. Clark (May 15, 2002)
- Employment Agreement - Tercica Medica Inc. and Timothy Lynch (Sep 10, 2002)
- International License and Collaboration Agreement - Genentech Inc. and Tercica Medica Inc. (Jul 25, 2003)
- Key Employee Agreement - Tercica Inc. and Howard Moore (Aug 17, 2003)
- Key Employee Agreement - Tercica Medica Inc. and Howard Moore (May 2002)
- Key Employee Agreement - Tercica Medica Inc. and John A. Scarlett (Feb 27, 2002)
- Key Employee Agreement [Amendment] - Tercica Medica Inc. and John A. Scarlett (May 15, 2002)
- License and Collaboration Agreement - Genentech Inc. and Tercica Medica Inc. (Apr 15, 2002)
- License and Collaboration Agreement [Amendment No. 1] - Tercica Medica Inc. and Genentech Inc. (Jul 25, 2003)
- Manufacturing Services Agreement - Tercica Medica Inc. and Cambrex Bio Science Baltimore Inc. (Dec 20, 2002)
- Manufacturing Services Agreement [Exhibits] - Tercica Medica Inc. and Cambrex Bio Science Baltimore Inc. (Dec 20, 2002)
Third Wave Technologies Inc.
TolerRx Inc.
- Collaboration Agreement - Genetech Inc. and TolerRx Inc. (Dec 23, 2002)
- Common Stock Purchase Warrant - TolerRx Inc. and Massachusetts Institute of Technology (Nov 20, 2001)
- Consulting Agreement - TolerRx Inc. and Herman Waldmann (Oct 27, 2000)
- Employment Agreement - TolerRx Inc. and Louis Vaickus (Jul 24, 2002)
- Licence Agreement - Cambridge University Technical Services Ltd. and TolerRx Inc. (Dec 8, 2000)
- Licence Agreement - Cambridge University Technical Services Ltd. and TolerRx Inc. (Sep 25, 2001)
- License Agreement - BTG International Ltd. and TolerRx Inc. (Sep 28, 2001)
- License Agreement - Isis Innovation Ltd. and TolerRx Inc. (Feb 1, 2001)
- License Agreement - Isis Innovation Ltd., University of Oxford and TolerRx Inc. (Dec 5, 2000)
Tongjitang Chinese Medicines Co.
Transgene SA
Trimeris Inc.
- Chief Executive Employment Agreement - Trimeris Inc. and Dani P. Bolognesi (Apr 21, 1999)
- Cooperation and Strategic Alliance Agreement - Trimeris Inc. and MiniMed Inc. (Apr 21, 1997)
- Development and License Agreement - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jul 1, 1999)
- Development and License Agreement [Amendment] - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jan 5, 2004)
- Development and License Agreement [Amendment] - Trimeris Inc., F. Hoffmann-La Roche Ltd. and Hoffman-La Roche Inc. (Jul 12, 2004)
- Employment Agreement - Trimeris Inc. and M. Ross Johnson (Dec 15, 1994)
- Employment Agreement - Trimeris Inc. and Matthew A. Megaro (Feb 23, 1995)
- Employment Termination and General Release Agreement - Trimeris Inc. and M. Ross Johnson (Apr 13, 1999)
- Executive Agreement - Trimeris Inc. and Robert R. Bonczek (Jan 7, 2000)
- Executive Employment Agreement - Trimeris Inc. and George W. Koszalka (Jun 21, 2004)
- Executive Employment Agreement - Trimeris Inc. and M. Nixon Ellis (Mar 31, 2000)
- Financing Agreement - Trimeris Inc. and Roche Finance Ltd. (Jul 9, 1999)
- License Agreement - Duke University and SL-1 Pharmaceuticals Inc. (Feb 3, 1993)
- License Agreement - New York Blood Center and Trimeris Inc. (Sep 9, 1997)
- Master Lease - FINOVA Technology Finance Inc. and Trimeris Inc. (May 28, 1998)
- NC-Durham-3518 Westgate Drive Lease - Hamad Jassim Althani and Blue Cross and Blue Shield of North Carolina (Nov 8, 1994)
- NC-Durham-3815 Westgate Drive Sublease - Blue Cross and Blue Shield of North Carolina and Trimeris Inc. (May 12, 1999)
- NC-Durham-4611 University Drive Sublease - Gilead Sciences Inc. and Trimeris Inc. (Oct 31, 2003)
- NC-Durham-Two University Place Lease - University Place Associates and Trimeris Inc. (Apr 15, 1999)
- Research Agreement - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Jan 1, 2000)
- Research Agreement [Amendment No. 1] - Trimeris Inc., F. Hoffman-La Roche Ltd. and Hoffman-La Roche Inc. (Nov 13, 2003)
- Settlement Agreement and Release - Trimeris Inc. and M. Nixon Ellis (Jul 1, 2004)
- Severance Agreement - Trimeris Inc. and Max N. Wallace (Jul 11, 1997)
Tularik Inc.
- Agreement and General Release - Tularik Inc. and John P. McLaughlin (Sep 30, 1999)
- CA-South San Francisco-213/217 East Grand Avenue and 317 Roebling Road Lease - Grand/Roebling Investment Co. and Shaman Pharmaceuticals Inc. (Jan 1, 1993)
- CA-South San Francisco-213/217 East Grand Avenue and 317 Roebling Road Lease [Assignment] - Shaman Pharmaceuticals Inc. and Tularik Inc. (Mar 27, 2001)
- CA-South San Francisco-Britannia Biotechnology Center Build-to-Suit Lease - Britannia Developments Inc. and Tularik Inc. (Apr 20, 1995)
- CA-South San Francisco-Britannia Biotechnology Center Build-to-Suite Lease - Britannia Biotech Gateway LP and Tularik Inc. (1998)
- CA-South San Francisco-One Corporate Drive Sublease - Tularik Inc. and AGY Therapeutics Inc. (Jan 25, 1999)
- CA-South San Francisco-One Corporate Drive Sublease - Tularik Inc. and Coulter Pharmaceuticals Inc. (May 1, 1999)
- CA-South San Francisco-One Corporate Drive Sublease - Tularik Inc. and IGEN International Inc. (Aug 20, 1999)
- CA-South San Francisco-Two Corporate Drive Sublease - Tularik Inc. and Genesoft Inc. (Nov 16, 1998)
- Collaboration Agreement - Tularik Inc. and Sankyo Co. Ltd. (Jun 10, 2002)
- Collaboration Agreement - Tularik Inc. and Japan Tobacco Inc. (Jun 1, 2000)
- Collaboration Agreement - Tularik Inc. and Knoll AG (Nov 1, 1998)
- Collaboration Agreement - Tularik Inc. and Sumitomo Pharmaceuticals Ltd. (Jan 31, 1995)
- Collaboration Agreement [Amendment No. 1] - Tularik Inc. and Japan Tobacco Inc. (Jan 1, 2001)
- Collaboration Agreement [Amendment No. 1] - Tularik Inc. and Knoll AG (Aug 15, 2000)
- Collaboration Agreement [Amendment No. 1] - Tularik Inc. and Sumitomo Pharmaceuticals Co. Ltd. (Mar 13, 1997)
- Collaboration Agreement [Amendment No. 2] - Tularik Inc. and Japan Tobacco Inc. (May 31, 2001)
- Collaboration and License Agreement - Tularik Inc. and Amgen Inc. (May 21, 2003)
- Collaboration and License Agreement - Tularik Inc. and Merck & Co. Inc. (Dec 22, 1996)
- Consulting Agreement - Tularik Inc. and Craig A.P.D. Saxton (Apr 18, 2002)
- License Agreement - Cold Spring Harbor Laboratory and Tularik Inc. (Oct 3, 1997)
- License Agreement - Tularik Inc. and Tularik Pharmaceutical Co. (Jun 1, 2000)
- Licensing Agreement - Eli Lilly and Co. and Tularik Inc. (Sep 24, 1999)
- Licensing Agreement [Amendment No. 1] - Tularik Inc. and Eli Lilly and Co. (Jan 10, 2001)
- Loan Agreement - Tularik Inc. and Steven L. McKnight (May 1, 2002)
- NY-Greenlawn-266 Pulaski Road Lease - Racanelli Trust and Tularik Inc. (Jul 23, 1998)
- Option Agreement - Tularik Inc., Japan Tobacco Inc. and Tularik Pharmaceutical Co. (Jun 1, 2000)
- Preliminary Research, Development and Marketing Agreement - Tularik Inc. and Japan Tobacco Inc. (Sep 8, 1998)
- Preliminary Research, Development and Marketing Agreement - Tularik Inc. and Japan Tobacco Inc. (Sep 20, 1998)
- Research Agreement - Cold Spring Harbor Laboratory and Tularik Inc. (Oct 3, 1997)
- Research Collaboration and License Agreement [Amendment No. 1] - Tularik Inc. and Syntex (U.S.A.) Inc. (Dec 19, 1997)
- Research Collaboration and License Agreement [Amendment No. 2] - Tularik Inc. and Syntex (U.S.A.) LLC (Aug 31, 2000)
- Research, Collaboration and License/Development Agreement - Tularik Inc. and Taisho Pharmaceutical Co. Ltd. (Mar 20, 1996)
- Research, Collaboration and License/Development Agreement [Amendment No. 1] - Tularik Inc. and Taisho Pharmaceutical Co. Ltd. (Jan 1, 1998)
- Research, Collaboration and License/Development Agreement [Amendment No. 2] - Tularik Inc. and Taisho Pharmaceutical Co. Ltd. (Jan 1, 1999)
- Screening Agreement - Tularik Inc. and Japan Tobacco Inc. (Aug 23, 1999)
VaxGen Inc.
- Assignment Agreement - VaxGen Inc. and Celltrion Inc. (Mar 25, 2002)
- Award Contract for Development and Testing of Vaccines Against Anthrax - National Institutes of Health and VaxGen Inc. (Sep 30, 2002)
- Award Contract for HIV Vaccine Production - VaxGen Inc. and National Institutes of Health (Jul 9, 1999)
- Award Contract for HIV Vaccine Production [Amendment] - VaxGen Inc. and National Institutes of Health (Sep 30, 2002)
- Award Contract for Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine - VaxGen Inc. and National Institutes of Health (Sep 30, 2003)
- CA-Brisbane-1000 Marina Boulevard Lease - Spieker Properties LP and VaxGen Inc. (May 20, 1998)
- CA-South San Francisco-347 Oyster Point Boulevard Sublease Agreement - TSI Communications and VaxGen Inc. (Sep 21, 2001)
- CA-South San Francisco-347/349 Oyster Point Boulevard Lease - Oyster Point Tech Center LLC and VaxGen Inc. (Oct 26, 1998)
- Clinical Trial Agreement - VaxGen Inc. (1999)
- Common Stock Purchase Agreement - VaxGen Inc. and Vulcan Ventures Inc. (Oct 15, 1999)
- Consulting Services Agreement - VaxGen-Celltrion Inc. and VaxGen Inc. (Jun 7, 2002)
- Contribution Agreement - VaxGen Inc., Nexol Biotech Co. Ltd., Nexol Co. Ltd., Korea Tobacco & Ginseng Corp. and J. Stephen & Co. Ventures Ltd. (Feb 25, 2002)
- Employment Agreement - VaxGen Inc. and Carmen M. Betancourt (Jan 28, 2002)
- Employment Agreement - VaxGen Inc. and Carter A. Lee (Apr 1, 1999)
- Employment Agreement - VaxGen Inc. and Donald P. Francis (Oct 2, 2001)
- Employment Agreement - VaxGen Inc. and George Baxter (Sep 5, 2000)
- Employment Agreement - VaxGen Inc. and James P. Panek (Feb 4, 2002)
- Employment Agreement - VaxGen Inc. and John Curd (May 3, 1999)
- Employment Agreement - VaxGen Inc. and Lance Ignon (Sep 25, 2001)
- Employment Agreement - VaxGen Inc. and Lance K. Gordon (Sep 6, 2001)
- Employment Agreement - VaxGen Inc. and Phillip Berman (Oct 10, 1997)
- Employment Agreement - VaxGen Inc. and Phillip Berman (Jun 1999)
- Employment Agreement - VaxGen Inc. and Phillip W. Berman (Feb 7, 2002)
- Employment Agreement - VaxGen Inc. and Piers Whitehead (Jul 1, 2002)
- Employment Agreement - VaxGen Inc. and Robert C. Nowinski (Jan 1, 1998)
- Employment Agreement - VaxGen Inc. and William L. Heyward (Jan 3, 2000)
- Employment Agreement - VaxGen inc. and Donald Francis (Jan 1, 1998)
- Employment Agreement - VaxGen inc. and Marc Gurwith (Oct 28, 2001)
- Joint Venture Agreement - VaxGen Inc. and Celltrion Inc. (Jun 7, 2002)
- Joint Venture Agreement - VaxGen Inc., Nexol Biotech Co. Ltd., Nexol Co. Ltd., Korea Tobacco & Ginseng Corp. and J. Stephen & Co. Ventures Ltd. (Feb 25, 2002)
- Land Purchase and Sale Agreement - Incheon Metropolitan City and VaxGen Inc. (Feb 25, 2002)
- Letter of Intent for Supply and Development Agreement - VaxGen Inc. and Pasteur Merieux Serums et Vaccins (Apr 10, 1998)
- Letter of Intent for Supply and Development Agreement [Amendment]- VaxGen Inc. and Pasteur Merieux Serums et Vaccins (Apr 30, 1999)
- License Agreement - VaxGen Inc. and Celltrion Inc. (Mar 25, 2002)
- License Agreement - VaxGen Inc. and VaxGen-Celltrion Inc. (Jun 7, 2002)
- License and Supply Agreement - VaxGen Inc. and Genentech Inc. (May 1, 1996)
- Loan and Security Agreement - VaxGen Inc. and Donald P. Francis (Dec 20, 2000)
- Loan and Security Agreement - VaxGen Inc. and Phillip W. Berman (Dec 20, 2000)
- Promissory Note - VaxGen Inc. and Robert C. Nowinski (Dec 20, 2000)
- Registration Rights Agreement - VaxGen Inc. and Genetech Inc. (May 5, 1997)
- Services Agreement - VaxGen Inc. and Genentech Inc. (Jan 1, 1999)
- Severance Agreement and Mutual General Release - VaxGen Inc. and Robert C. Nowinski (Dec 2000)
- Stock Option Agreement - VaxGen Inc. and Lance Gordon (Sep 6, 2001)
- Sub-License Agreement - VaxGen Inc. and Celltrion Inc. (Mar 25, 2002)
- Sub-License Agreement - VaxGen Inc. and VaxGen-Celltrion Inc. (Jun 7, 2002)
- Subcontract Agreement - BBI Biotech Research Laboratories Inc. and VaxGen Inc. (May 1, 1999)
- Supply Agreement - VaxGen inc. and Celltrion Inc. (Mar 25, 2002)
ViaCell Inc.
- Co-Development and License Agreement - ViaCell Inc. and Gamete Technology Inc. (Jul 15, 2003)
- Co-Development and License Agreement - ViaCell Inc. and Gamete Technology Inc. (Oct 28, 2004)
- Collaboration Agreement - Amgen Inc. and ViaCell Inc. (Dec 23, 2003)
- Directorship Agreement - ViaCell Inc. and George Daly (Aug 13, 2003)
- Directorship Agreement - ViaCell Inc. and Jan van Heek (Sep 12, 2002)
- Directorship Agreement - ViaCell Inc. and Kevin Wilson (Dec 15, 2001)
- Directorship Agreement - ViaCell Inc. and Paul Hastings (Dec 15, 2001)
- Directorship Agreement - ViaCell Inc. and Vaughn Kailian (Nov 4, 2003)
- Directorship Agreement - ViaCell inc. and Roland Scollay (Dec 15, 2001)
- Early Separation Agreement and Mutual General Release - ViaCell Inc. and Cynthia A. Fisher (Feb 7, 2001)
- Employment Agreement - ViaCell Inc. and George Daley (Dec 18, 2000)
- Employment Agreement - ViaCell Inc. and Grant Bogle (Jul 1, 2002)
- Employment Agreement - ViaCell Inc. and Grant Boyle (Feb 25, 2004)
- Employment Agreement - ViaCell Inc. and Jeffrey Sacher (Oct 26, 2002)
- Employment Agreement - ViaCell Inc. and Jeffrey Sacher (Jan 2, 2004)
- Employment Agreement - ViaCell Inc. and Kurt Gunter (May 14, 2001)
- Employment Agreement - ViaCell Inc. and Marc Beer (May 2, 2000)
- Employment Agreement - ViaCell Inc. and Mary Thistle (Sep 29, 2000)
- Employment Agreement - ViaCell Inc. and Morey Kraus (Apr 11, 2000)
- Employment Agreement - ViaCell Inc. and Seth P. Finklestein (Jun 25, 2001)
- Employment Agreement - ViaCell Inc. and Stephan Wnendt (Dec 29, 2004)
- Employment Agreement - ViaCell Inc. and Stephen P. Dance (Mar 11, 2004)
- Exclusive Patent License Agreement - Massachusetts Institute of Technology and ViaCell Neuroscience Inc. (Aug 20, 2002)
- Germany-Langenfeld-98 Berghausener Street Lease - WHL Grundstucksgemeinschaft GbR and Kourion Therapeutics AG (Oct 1, 2002)
- Human Umbilical Cord Blood Processing Services Agreement - Viacord Inc. and Progenitor Cell Therapy LLC (Dec 1, 2001)
- KY-Hebron-2375 Progress Drive Lease - Dugan Financing LLC and ViaCell Inc. (Apr 12, 2002)
- License Agreement - General Hospital Corp. and Cerebrotec Inc. (Jan 18, 2001)
- License Agreement - General Hospital Corp. and ViaCell Endocrine Science Inc. (Mar 15, 2002)
- License Agreement - Tyho Galileo Research Laboratory and ViaCell Inc. (Sep 1, 2004)
- MA-Boston-131 Clarendon Street Sublease - AIDS Action Committee of Massachusetts Inc. and ViaCell Inc. (Dec 27, 2000)
- MA-Boston-551 Boylston Street Lease - Molded Antennas for Telecommunications Inc. and Viacord Inc. (Apr 20, 1999)
- MA-Cambridge-245 First Street Lease - MA-Riverview/245 First Street LLC and ViaCell Inc. (Dec 2003)
- MA-Cambridge-26 Landsdowne Street Sublease - ARIAD Corp. and ViaCell Inc. (Nov 1, 2001)
- MA-Worcester-One Innovation Drive Sublease - Advanced Cell Technology Inc. and ViaCell Inc. (Apr 11, 2002)
- Non-Exclusive License Agreement - ViaCell Inc. and SmithKline Beecham Corp. d/b/a GlaxoSmithKline (Jan 1, 2003)
- Patent Option Agreement - Massachusetts Institute of Technology and Cerebrotec Inc. (Jun 8, 2001)
- Research Agreement - ViaCell Inc. and Genzyme Corp. (Dec 13, 2004)
- Research Agreement re: Amyotrophic Lateral Sclerosis - ViaCell Inc. and General Hospital Corp. (Jan 1, 2002)
- Research Agreement re: Muscular Dystrophy - ViaCell Inc. and General Hospital Corp. (Jan 1, 2002)
- Services Agreement - Viacord Inc. and University of Cincinnati (Dec 30, 1994)
- Severance Agreement - ViaCell Inc. and Jeffrey Sacher (Jan 2, 2004)
- Singapore-Singapore Science Park II Lease - Singapore Science Park Ltd. and ViaCell Inc. (Mar 25, 2002)
- Warrant for the Purchase of Shares - ARE-One Innovation Drive LLC and t.Breeders Inc. (Feb 24, 2000)
- Warrant to Purchase Shares - ViaCell Inc. and Amgen Inc. (Apr 9, 2002)
- Warrant to Purchase Shares - ViaCell Inc. and General Electric Capital Corp. (Oct 16, 2003)
ViroLogic Inc.
- 2000 Equity Incentive Plan - ViroLogic Inc. (Jun 7, 2000)
- CA-South San Francisco-270 East Grand Avenue Sublease - ViroLogic Inc. and Raven Biotechnologies Inc. (May 25, 2001)
- CA-South San Francisco-335 Oyster Point Boulevard Lease - Trammell Crow Northern California Development and ViroLogic Inc. (Nov 23, 1999)
- CA-South San Francisco-343 Oyster Point Boulevard Sublease - Virologic Inc. and diaDexus Inc. (May 17, 2001)
- CA-South San Francisco-343 Oyster Point Boulevard Sublease - diaDexus Inc. and ViroLogic Inc. (Jun 1, 2002)
- CA-South San Francisco-343 Oyster Point Boulevard Sublease [Amendment No. 1] - diaDexus Inc. and ViroLogic Inc. (Aug 31, 2003)
- CA-South San Francisco-343 Oyster Point Boulevard Sublease [Termination] - Virologic Inc. and diaDexus Inc. (Jun 1, 2002)
- CA-South San Francisco-345/349 Oyster Point Boulevard Lease - Oyster Point Tech Center LLC and ViroLogic Inc. (May 25, 1999)
- Employment Agreement - ViroLogic Inc. and Martin H. Goldstein (Feb 7, 1996)
- Employment Agreement - ViroLogic Inc. and William D. Young (Sep 29, 1999)
- Equipment Financing Agreement - Lease Management Services Inc. and ViroLogic Inc. (Oct 16, 1996)
- Exchange Agreement - ViroLogic Inc. (Nov 14, 2002)
- Executive Severance Benefits Agreement - ViroLogic Inc. (2000)
- Immunity Agreement - Roche Molecular Systems Inc. and ViroLogic Inc. (Aug 4, 1997)
- Intellectual Property Security Agreement - ViroLogic Inc. and SDS Merchant Fund LP (Nov 14, 2002)
- Loan and Security Agreement - MMC/GATX Partnership No. I and ViroLogic Inc. (Jan 30, 1998)
- Master Equipment Lease Commitment - Pentech Financial Services Inc. and ViroLogic Inc. (Mar 28, 2000)
- Master Lease Agreement - Citicorp Vendor Finance Inc. and ViroLogic Inc. (Apr 16, 2002)
- Master Lease Agreement - De Lage Landen Financial Services Inc. and ViroLogic Inc. (Jan 29, 2001)
- Master Lease Agreement - General Electric Capital Corp. and ViroLogic Inc. (Sep 14, 2000)
- Master Lease Agreement [Equipment Schedule No. 4] - General Electric Capital Corp. and ViroLogic Inc. (Aug 14, 2000)
- Master Lease Agreement [Equipment Schedule No. 5] - General Electric Capital Corp. and ViroLogic Inc. (Aug 14, 2000)
- Registration Rights Agreement - ViroLogic Inc. and Zesiger Capital Group LLC (Mar 22, 2002)
- Securities Purchase Agreement - ViroLogic Inc. (Nov 14, 2002)
- Securities Purchase Agreement - ViroLogic Inc. and Biotech Target NV (Mar 22, 2002)
- Securities Purchase Agreement - ViroLogic Inc., SAC Capital Associates LLC, SDS Merchant Fund LP, Narragansett I LP, Narragansett Offshore LTD, Castle Creek Healthcare Partners LP, CCL Fund LLC, Crestwood Capital Partners LP, Crestwood Capital International LP, Crestwood Capital Partners II LP, Bridgewood Capital Partners LP, Anvers Healthcare Investors LP, Anvers II LP and Anvers LP (Jun 29, 2001)
- Security Agreement - ViroLogic Inc. and SDS Merchant Fund LP (Nov 14, 2002)
- Stock Purchase Agreement - ViroLogic Inc. and Pfizer Ireland Pharmaceuticals (Nov 14, 2002)
- Warrant to Purchase Series C Preferred Stock - ViroLogic Inc. and Pentech Financial Services Inc. (Mar 31, 2000)
Wyeth
Sponsored Links
|
